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ABSTRACT OF THE DISSERTATION
INTRACELLULAR SIGNALING AND TRAFFICKING IN CANCER: ROLE OF
RAB5-GTPASE IN MIGRATION AND INVASION OF BREAST CANCER CELLS
by
Nicole C. Porther
Florida International University, 2015
Miami, Florida
Professor Manuel A. Barbieri, Major Professor
Metastasis is characterized pathologically by uncontrolled cell invasion, proliferation,
migration and angiogenesis. Steroid hormones, such as estrogen, and growth factors,
which include insulin growth factor I/II (IGF-1/IGF-2) therapy has been associated with
most if not all of the features of metastasis. It has been determined that IGF-1 increases
cell survival of cancer cells and potentiate the effect of E2 and other ligand growth
factors on breast cancer cells. However not much information is available that
comprehensively expounds on the roles of insulin growth factor receptor (IGFR) and Rab
GTPases may play in breast cancer. The latter, Rab GTPases, are small signaling
molecules and critical in the regulation of many cellular processes including cell
migration, growth via the endocytic pathway. This research involves the role of Rab
GTPases, specifically Rab5 and its guanine exchange factors (GEFs), in the promotion of
cancer cell migration and invasion. Two important questions abound: Are IGFR
stimulation and downstream effect involved the endocytic pathway in carcinogenesis?
What role does Rab5 play in cell migration and invasion of cancer cells? The hypothesis
is that growth factor signaling is dependent on Rab5 activity in mediating the
v

aggressiveness of cancer cells. The goal is to demonstrate that IGF-1 signaling is
dependent on Rab5 function in breast cancer progression. Here, the results thus far, have
shown that while activation of Rab5 may mediate increased cell proliferation, migration
and invasion in breast cancer cells, the Rab5 GEF, RIN1 interacts with the IGFR thereby
facilitating migration and invasion activities in breast cells. Furthermore, endocytosis of
the IGFR in breast cancer cells seems to be caveolin dependent as the data has shown.
This taken together, the data shows that IGF-1 signaling in breast cancer cells relies on
IGF-1R phosphorylation, caveolae internalization and sequestration to the early
endosome RIN1 function and Rab5 activation.
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CHAPTER 1
The scope of this chapter is to introduce the concept of intracellular signaling
cascade in normal and cancer cells with specific focus on early endocytosis and growth
factor receptor activity upon ligand stimulation. The role of Rab GTPases, key metastatic
traits (cell invasion and cell migration), and a short overview of the insulin growth factor
pathway will be covered in cancer cells. Overall the information creates an outline for the
research hypothesis.
1.1 Introduction
The last decade in cancer research has seen great strides in identifying the interplay
between the stroma and tumor environment in cancer progression. Briefly, cancer has
been long viewed as a disease consisting of transformed or mutated cells that acquire
hyper-proliferative, invasive and limitless survival capacities. While this in itself is true,
it was a limited approach as ensuing therapeutic cancer intervention strategies sought to
target only the tumor cell. However, carcinogenesis and tumor progression are viewed
not as an autonomous cell-centered condition, but rather as a disease involving complex
multicellular (stromal cells) crosstalk within a newly formed tissue. This breast cancer
tissue or the tumor matrix hijacks key cellular functions which have evolved as
cornerstones of metastasis. The primary focus of this review will delve on the early
endocytic pathway in modulating one of the most important hallmarks of cancer cell
metastasis; cell migration and cell invasion in response to growth factor stimulation.
1.2 The Traits of Cancer
Hanahan and Weinberg published a landmark paper referred to as the ‘Hallmarks of
Cancer’ that encapsulated the key stages from tumorigenesis to metastasis in cancer
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progression 53. The six phases described, though distinctive in nature, complemented each
other and worked in concert in the transformation a normal cell to a cancer cell. These
hallmarks were later updated to ten key traits by the authors and include but not limited to
tumor induced inflammation to the constitution and signaling interactions of the tumor
microenvironment in the maintenance of cancer phenotypes. For this project, three
hallmarks were studied: sustained proliferation, migration and invasion.
1.2.1. Always On: Growth Factor sustained proliferation
The multiplication of cells relies on biochemical molecules called growth factors141
that are highly bio-reactive despite their low copy number within tissues. Their primary
functions include cell growth, differentiation and survival thereby making them targets
for opportunistic pre-cancer cells. During normal body function, homeostasis is achieved
by the regulation of the production and secretion of growth signals (mitogens) and the
cells that respond and progress from a quiescent status to the growth and division
cycle141.
Cancer cells, on the other hand, modulate these mitogenic signals and evolve as
autonomous growth signal entities64,71,141. They upset the delicate balance by promoting
the binding of multiple growth factors to cell surface receptors, synthesize growth signals
that can either bind to their own receptor forming an autocrine loop or influence the
secretion of more growth factors by normal cells into the stroma

12,25

, which then binds

again to the receptors on the cancer cells, creating a paracrine feedback loop.
Within the cancer cell, activated receptors transduce signals via the intracellular
signaling pathway resulting in increased cell proliferation, survival and size and
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translation of more modified cell surface receptors which continue to feed into the selfsufficient, machinery created by cancer cells53,117. These receptors may also be altered
where they are permanently activated and hyper-sensitive to various stimuli or nonspecific ligand binding.
Mutations within the signaling pathway (besides the receptor) can also mediate a
sustained proliferative response in cancer cells independent of growth factor stimulus.
For example, Ras is a known downstream signaling protein in the receptor mediated
pathway and one in four (25%) of all human tumors have the mutant Ras gene switched
on36.
1.2.2. Metastasis
In cancer, a solid tumor cannot expand and spread without a series of synchronized
events. Metastasis is a multistep process that encompasses the modulation of basement
membrane permeability at the tumor site; decreased cell attachment, tumor cell invasion,
cell migration and proliferation in response to survival and pro-angiogenic signals.37
Though the classical belief regards metastasis as a late event in cancer progression, it is
acknowledged that metastatic signaling events can be initiated during early tumorigenesis
and progression. Specifically, cell origin and oncogenic alterations influence the
molecular characteristics of a tumor and its malignancy potential.134
While the metastatic potential is relatively small for tumor cells, there is an epigenetic
influence that leads to the transformation from non-metastatic to aggressive tumor
cell37,53. It is not a passive event where cancerous cells are sloughed off a tumor and
shuttled to distal sites for colonization. On the contrary, it is a highly active process that
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involves chemotactic signals that drive cell motility, release of proteases and other
enzymes that degrade the extracellular matrix (ECM), avoidance of the immune response
and apoptotic, anoikis and amorphotic signals, unresponsiveness to growth inhibitory
signals and as mentioned earlier, growth factor independent proliferation53,117.
Furthermore changes in cell adhesion molecules (integrins, cadherin-catenins) and
protease expression have been linked to tumor invasion and metastasis1,122. Within recent
years, interest has been generated regarding the role of endocytosis in tumor progression
and metastasis, particularly the trafficking of metastatic factors that mediate two of the
necessary stages that characterize metastasis; cell migration and cell invasion.67,97,122
1.2.3. Characteristics of Invading cells
Cell migration and invasion are key components of metastasis where atypical
epithelial cells have acquired phenotypic changes that mediate the spread of the cancer to
distant tissues and organs. Cell migration is a highly regulated event and is controlled by
the expression and localization of specific cell surface receptors, such as Integrins,
Epithelial Growth Factor (EGF)- Receptor (EGFR), Insulin Growth Factor (IGF)Receptor (IGFR), the reorganization of cytoskeletal elements, and the directed trafficking
of molecules required for cell signaling and adhesion.8,110
There are three distinctive types of morphologic events that are affiliated with early
metastasis- epithelial mesenchymal transition (EMT)71,147, collective invasion41,42 and
amoeboid transcription85,115. Most recently a fourth concept, inflammatory induced
invasion, has been identified as another morphogenic episode in metastasis64,93,106.
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1.2.3.1. Epithelial Mesenchymal Transition
The most common of the morphogenic episodes associated with metastasis, EMT is a
process where cells elongate, secrete ECM proteases which degrade the matrix and
migrate out53. Transforming Growth Factor β (GFβ) induces EMT via RAS-GTPases
signaling102 and facilitate changes to a more invasive phenotype in cancer cells in
response to ligand growth factor stimuli, specifically IGF-1133. Within the human body,
tissue is comprised of two types of cells that aggregate and perform a specialized task;
epithelial cells and mesenchymal cells. Epithelial cells are atypical in shape, adherent to
other cells to form layers within the tissue; of which the latter is interspersed with
structural carbohydrates and proteins that serve as the extracellular matrix. Mesenchymal
cells are solitary cells that possess a strong migratory potential. Yet most cancers (at least
90%) are epithelial in origin127.
Normal epithelial cells secrete E-cadherin, a regulatory protein that maintains adhesive
(glue-like) structure between the cells and suppresses the release of pro-migratory growth
molecules thereby ensuring that the cells remain in senescence and contact inhibition.
With the advent of metastasis, E-cadherin function is lost and there is a gradual shift to
N-cadherin expression; which is expressed in migrating cells.133 After EMT, motile cells
migrate mesenchymally where they extend projections called lamellipodia on the front of
the cells while binding to specific surface cell surface receptors such as betaintegrins19,147. This movement is largely regulated by several small GTPases like HRAS, N-RAS, K-Ras, Rac1, Rho and Cdc42 GTPases activity138.
Actin dependent contractile propulsion push the cell body forward while rear is
released and integrin signaling engage the secretion of matrix metalloproteinases
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(MMPs); degrading the ECM and generating gaps for cells to pass through. EMT cells
are therefore self- directing and path-generating given the cells’ proteolytic activity as
they migrate.142
The most unique aspect of EMT and tumor cell migration is the ability to survive
without normal matrix components and the evasion of anoikis or adherence to foreign
ECM as they move34.
1.2.3.2. Amoeboid Transcription
Typically aggressive, motility in amoeboid transcription (AT) differs from EMT
where protease- independent elongated cells acquire a spherical shape and then are
deformed upon passage through interstices already present in the ECM115. Within AT cell
migration and invasion is controlled by the Rho family of GTPases109,131.
Unlike mesenchymal migration, suppression of Smurf1 influences RhoA activation,
and initiates a signaling cascade that effect the generation of the spheroid structure and
locomotion.

135

The high metastatic capacity of amoeboid transcription can be attributed

to the tumor cells’ competence in warping the collagen bed in the ECM which allows the
cells to become invasive145.
1.2.3.3. Collective Invasion
As the name implies, this type of invasion involve the movement of a group of cancer
cells to neighboring tissues and organs. However, unlike EMT and amoeboid
transcription, this type of invasion is somewhat controversial and believed to be less
aggressive as it lacks key characteristics that facilitate metastasis.
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On one hand, it is believed that during collective invasion, cells on the leading edges
of the collective invasion zones may acquire partial EMT–like traits and drive the
intravasation process26.

For example, cancer cells expressing high levels of basal

epithelial markers such as cytokeratin 14 and p63 led invasion of the collective group of
cells in different subtypes of breast cancer26. Stromal fibroblasts via Rho activation also
initiate collective invasion in cancer cells47.
The other theory is that a unique mechanism distinct from EMT, may be utilized by
tumor cells undergoing collective invasion39.
1.2.3.4. Inflammation Induced Invasion
If EMT can be viewed as a simplistic feature of tumor cell invasion and amoeboid is
the aggressive, complicated version, inflammation induced invasion can be the product of
the aforementioned invasive processes. The crosstalk between the stroma and tumor cells
in the microenvironment influence the invasive potential of tumor cells. In breast cancer,
it was determined that cancer cells signaled the secretion of chemokines by mesenchymal
cells located in the stromal bed, and these chemokines stimulate cancer cells to become
aggressive and invasive65.
Immune cells at tumor sites enable invasion by supplying MMPs. Tumor associated
macrophages (TAMs) furnish cancer cells with growth factors and cancer cells
reciprocate by providing colony stimulating factor 1 (csf1) thereby driving increasingly
invasive behavior in tumor cells112.
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1.3 Growth Factor Driven Signaling in Tumor Metastasis
Metastatic factors such as HGF, EGF, TGFβ and IGF are known to activate the
endosomal pathway and the mechanisms can be analogous at key junctions thereby
promoting a migratory response in tumor cells.
These Receptor Tyrosine Kinases (RTKs) can be internalized through two principal
pathways: clathrin coated pits or caveolae. We will briefly discuss a few of these growth
factors and their possible roles in early endocytic trafficking and tumor progression. A
detailed review of most metastatic growth factors (whether mentioned here or not) with
the exception of IGF-1 can be accessed from the following reference.61
1.3.1. Epithelial Growth Factor
Perhaps the most studied and understood receptor trafficking systems, EGFR signaling
is a crucial aspect of breast cancer metastasis11,15,38,88,90. Epithelial Growth Factor
Receptor signaling is heavily regulated by endocytosis where EGF triggers the
internalization of the EGFR complex via clathrin-mediated endocytosis57,123, clathrinindependent mechanisms104and subsequent activation of the mitogen-activated protein
kinases (MAPK) signaling pathway.
The Arf GAP with Rho GAP domain, ankyrin repeat, and PH domain 1 (ARAP1)
protein controls EGFR trafficking via Rab5 activation and affect the rate of EGFR signal
attenuation

149

and ensuing MAPK signaling. A recent study highlighted the role of

clathrin-mediated endocytosis Epithelial Growth Factor directed chemotactic invasion of
breast cancer98. Rab5a is characterized as a significant molecule in ovarian cancer upon
EGF stimulation.155
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On the other hand, Rab5c has been implicated in EGFR signaling by affecting integrin
recycling and triggering cell invasion in some breast cancer cells.103 Rab11a is known to
modulate EGFR recycling and have a differential effect on proliferation and motility of
MCF10A breast cells.107

Inhibition of Rab35 fostered a shift from epithelial to

mesenchymal status, and led to an increase in cell migration and invasion in tumor cells
in response to EGFR activation. 3

1.3.2. Hepatocyte Growth Factor
It has been previously reported that HGF signaling involves the activation of the
Hepatocyte Growth Factor Receptor (MET) and the receptor undergoes rapid endocytosis
via clathrin dependent and independent endocytic pathways.
Hepatocyte Growth Factor Receptor trafficking requires Rab5 and facilitates focal
adhesion turnover, actin remodeling and sustained MAPK signaling thereby underscoring
its role in tumorigenesis, cell migration and invasion. 52 Further studies show that human
growth hormone (HGH) exposure in cells expressing naturally occurring Met mutants
boosted endocytic activity and led to tumor metastasis.61
1.3.3. Transforming Growth Factor β
The TGFβ has an interesting dual role in cancer. As indicated earlier, metastasis
necessitates the transformation from epithelial cell to mesenchymal cell phenotype.
During this process, TGFβ has been characterized in its role in epithelial
mesenchymal transition (EMT) and tumorigenesis as having both a positive and
negative influence in the promotion of cell migration and invasion.29
9

The TGFβ signaling involves the internalization of the Transforming Growth
Factor β Receptor (TGFβR) through clathrin dependent and independent pathways
and was found in EEA1 and caveolin positive vesicles, respectively.31 Furthermore,
the intensity of TGFβ was sustained through recycling of the receptor through ligand
stimulation and clathrin internalization though Rab11 irrespective of ligand
activation via Rab4 activity91.
It was also noted that lipid raft-caveloar induced rapid receptor turnover by the
competitive binding of the internalized TGFβR with a small intracellular inhibitory
protein, mothers against decapentaplegic homolog 7 (Smad7) coupled with SMAD
specific E3 ubiquitin protein ligase 2 (Smurf2); of which this Smad7-Smurf7 complex
tags the TGFβR for degradation31 through the proteasomal or lysosomal pathways.
While there is a dearth of information regarding the direct involvement of TGFβR
endocytosis in cancer metastasis, it was recently reported that delayed endocytosis of the
TGF-βRII was due to a gain-of-mutation of the receptor and enhanced TGF-β signaling.
This resulted in a more invasive phenotype of human oral squamous carcinoma108.
1.3.4. Insulin Growth Factor
The IGF system is a complex highly regulated network and its influence in cancer has
been extensively reviewed by several groups 6,14,17,77,82,116. Here, the key features of IGF1 and the downstream effectors in cancer biology is recapitulated. The IGF-1 system is
comprised of the IGF ligands (IGF-1 and IGF-2), cell-surface receptors that mediate the
biological effects of the IGFs, including the IGF-1 receptor (IGF-1R), the IGF-2 receptor
(IGF-2R), the insulin receptor (IR), as well as a family of IGF-binding proteins
(IGFBPs).
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Most IGF-1 in circulation is produced by the liver, and IGF-1 synthesis and action is
linked to the growth hormone (GH) system, typically referred to as the GH/IGF axis70.
IGF-1 is also synthesized in other organs and tissue where autocrine and paracrine
mechanisms are essential. Insulin Growth Factor-1 activity is modulated in part by
IGFBPs, where close to 99% is bound, leaving a small percentage to exert its influence
on the body51.
Insulin Growth Factor-1 signaling may be both IGF-1R dependent or independent.
Insulin Growth Factor signaling is initiated by the binding of the IGF-1 or IGF-2 ligand
to the IGF-1R/ IGF-2R and the subsequent phosphorylation of tyrosine residues of
specific cytosolic kinase domains35,82,111.
The activated receptor transduces this phosphorylation activity to insulin receptor
substrates (IRS) and Shc adaptor proteins; and starts a signaling cascade that involves the
MAPK and phosphatidylinositol 3-kinase (PI3K) intracellular signaling pathways that are
responsible for the diverse target actions of these growth factors, which include increases
in cell division, cell size, protein synthesis, cell migration, and inhibition of apoptosis78.
Many of the signaling elements that are downstream from tyrosine kinase activation have
been characterized, but several of the molecular events (such as the possible
internalization of the receptor) that may occur before or concomitantly with kinase
activation and whether these early events can influence the ultimate outcome of IGF-1stimulated signal transduction have not been determined.
The IGF system is integral to a number of cellular processes ranging from normal
growth and development of specific organs, such as in the nervous system, in
which IGF signaling regulates neuronal proliferation, apoptosis, and cell survival82,111,116.
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Conversely, IGF also has a critical role in pathological situations, particularly
tumorigenesis and a growing body of epidemiological studies has implicated free IGF-1
serum levels as a risk factor for the development and progression of breast, prostate,
colon, and lung cancer35,46,111. The adverse effect of IGF is unsurprising given the
delicate balance that must be maintained, and the diverse and extensive regulatory
function of IGF-1 in maintaining homeostasis.
Insulin Growth Factor-1 does not induce mutations but may promote cancer via the
apoptotic pathway as it is a survival factor similar to PDGF, EGF and act via the IGF-1R
to stimulate the phosphatidylinositol 3-kinase PI3K /Akt pathway49,78. Kurmasheva et al.
maintained that the IGF-1 mediates cell survival in adverse physiological conditions
ranging from oxidative stress, low nutrient, cytoxic or hypoxic environments.74 Insulin
Growth Factor-1 facilitates cell survival by regulating the expression of pro- and antiapoptotic proteins.

Specifically, IGF-1 binding to the IGF-1R ligand induces the

activation of Akt which phosphorylates the pro-apoptotic protein Bad78. This
phosphorylation activity in turn, induces a conformational change in Bad and inhibited its
interaction with the anti-apoptotic Bcl proteins and the subsequent activation of the
caspase chain thereby allowing the transformed and pre-cancerous cells to escape
apoptosis and survive.
Insulin Growth Factor-1 has been demonstrated to increase VEGF expression of tumor
cells and inhibit apoptosis by binding to caspase 9 which is unable to cleave caspase 3
and halting the caspase cascade to apoptosis132. It is known that IGF-1 protect scells from
anoikis which is a process that ensures cells undergo apoptosis when they are detached
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and no longer able to adhere to the extracellular matrix and this protective action may be
conferred to pre-metastatic tumor cells.
Insulin Growth Factor-1 levels increase in response to ECM degradation by matrix
metalloproteinases (MMPs) and ensure the survival and hyperproliferative state of
cancerous cells.128 Insulin Growth Factor-1 increases the pro-metastatic property of
cancer cells by reorganizing integrin receptors, and modulating the E-cadherin/ β-catenin
complex which in turn, increase MMPs expression and the migratory potential of the
cells133 β-catenin as a result, accumulates in the nucleus (possible translocation from
cytoplasm), and there is an increase cell proliferation by inactivation of glycogen
synthase kinase 3B (GSK3B)30.
Insulin Growth Factor-1 also facilitates the crosstalk between the PI3K and MAPK
pathways via Ras (upstream effector of the p85subunit of PI3K) which potentiates both
the cell proliferation and cell survival cell response. Some interesting studies that
proffered other links between IGF-1 and cancer where an inverse relationship exists
between the tumor suppressor genes p53 and Wnt1 and low expression of the genes was
dominant in highly aggressive breast cancer cells (estrogen receptor negative; ER-)35.
It is now known that that circulating IGF-1 levels are higher in breast cancer patients
compared with normal controls
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while high IGF levels are associated with increased

risk of breast cancer in pre-menopausal women.54
There also exists an inherent relationship between IGF-1 and estrogen (E2). Estrogen
has been shown to increase IGF-1 and IGF-1R expression and transcription, with the
latter having a positive feedback and activating the IGF-1 signal pathways35.
Furthermore, it has been determined that the E2 antagonist, tamoxifen and other
13

antiestrogens suppress IGF-1 gene expression and MAPK and PI3K pathways.27
Conversely in tamoxifen resistant cancer cells, IGF-1R expression as well as MAPK
phosphorylation were activated in tamoxifen resistant cancer cells87.
1.3.4.1. IGF-1R and Endocytosis
Despite the limited information regarding the function of endocytosis in IGF-1 driven
tumorigenesis, recent evidence points to an increase in cell proliferation and inhibition of
apoptosis upon IGF-1R stimulation and ensuing internalization and co-localization with
clathrin and caveolin-1 in Ewing sarcoma cells.86 Insulin Growth Factor-1 receptor is also
localized in the nucleus in prostate, renal and breast tumor cells after translocation from
the cell surface via clathrin mediated endocytosis.2 Whether early endocytosis of IGF-1R
is key in regulating tumorigenesis and cancer metastasis remains to be seen.
1.4. Endosomal Signaling and Intracellular Trafficking
Within a cell, homeostatic conditions and normal cell mechanisms and processes such
as differentiation, cell migration, proliferation, gene transcription, vesicular trafficking,
cytoskeleton modulation and organization and nuclear assembly are tightly regulated and
rely heavily on the small GTPase activity.83,139 These monomeric GTPases are
homologous to the heteromeric G-proteins where they hydrolyze the active bound form
of GTP to the inactive bound form thereby acting as molecular switches66 and cycling
between the active GTP and inactive GDP bound forms via three classes of regulatory
proteins: the GTPase activating proteins (GAPs), guanine nucleotide disassociation
inhibitors (GDIs) and guanine exchange factors (GEFs)18.
One of the largest sub-families of the large Ras superfamily of small GTPases is the
Rab proteins153. They extend across more than 60 members in mammals and are highly
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conserved from yeast to humans. The Rab family of proteins plays important regulatory
roles in vesicle formation and transportation from plasma membrane to various
organelles within the cell through the recruitment of small factors that include
phosphatases, kinases and docking , adaptor proteins as well as actin filaments and
microtubules in cell migration and mitosis.126
In this way, given the myriad of functions that Rab proteins regulate during
intracellular trafficking, it is unsurprising that there is a marked interest in Rab GTPase
function and expression in tumor progression. The Rab proteins have been specifically
linked to the deregulation of several signaling pathways in several cancers and also been
implicated in the promotion of abnormal proliferation, migration and invasion of
epithelial cells in tumor progression because of stimulation of membrane bound growth
factor receptors23.
Disruption of endocytosis confers growth factor and ECM self-sufficiency to cancer
cells as discussed earlier, imparts growth factor and extracellular matrix autonomy to
cancer cells by bypassing key endocytic processes such as lysosomal degradation and
instead promote the recycling of growth factors as well as integrins. In response to this
deviant endocytic pathway, cellular processes such as adhesion, migration, proliferation,
polarity, asymmetrical division and overall survival are modified and represent emerging
hallmarks of cancer92.
1.4.1. Differential Expression of Rab GTPases in Cancer Cells
Though the functional role of Rab GTPases have not been fully characterized in
cancer cells, studies have shown that at the genomic levels, there is a deregulated
expression of Rab in tumor cells which also differs within specific tissue.
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The GTPase, Rab23, is over-expressed in bladder

58

, gastric

59

and ovarian

24

carcinoma whilst it is purported to be down-regulated in triple negative breast cancer21,22.
Similarly Rab25 have differing expression levels with increased expression in estrogen
and progesterone receptor positive breast cancer
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and suppression in colon and head

and neck tumors5,100.
Down-regulation of Rab38 may be associated with metastasis in melanoma95. In
gastric cancer, other Rabs have been implicated such as Rab32, Rab34 and Rab40C of
which hypermethylation of the Rab32 gene led to down-regulation in the tumor
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and

conversely suppression of specific miRNAs; miR-9 and let-7a promoted the efflux of
Rab34 and Rab40c expression84.
Likewise, alterations in miRNA expression (specifically miRNA-451 and miRNA101) led to non-small lung cancer via over-expression of Rab14
Rab5a in hepatocellular carcinoma,

119

137

and upregulation of

respectively. Furthermore in highly metastatic

lung cancer, post-translational modifications and in increase in gene expression mediated
elevated Rab37 and Rab7 levels.

99,143

In liver cancer, Rab1b, Rab4b, Rab10, Rab22 and

Rab24 are over-expressed 55 whilst Rab1a is higher than normal in tongue cancer121.
It is also known that Rab2B levels are elevated in colon carcinoma101 while in thyroid
associated adenomas, Rab5a and Rab7 are upregulated75. Breast cancer metastasis and
worse outcomes in patients have been attributed to high levels of Rab31 and Rab5a72,146.
1.4.2. The Role of Rab GTPases in regulating Cell Migration
As mentioned earlier, one of the key characteristics of metatastic cells is the ability to
migrate and invade through a compromised ECM and translocate to distal sites, thereby
forming secondary tumors or metastases53.
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Rab35, a gtpase involved in Rho mediated actin cytoskeletal reorganization, is
upregulated in migrating breast cancer cells in response to Wnt activation. Chau et al.
demonstrated that actin dependent protrusions were generated by Rab35 acting on Rho
GTPases28. The silencing of Rab35 inhibited cell migration in MCF7 breast cancer
cells.157 Conversely, Rab35 mitigates cell migration in brain tumor cells 3 which suggest
that Rab GTPase modulation of cell migration may be tissue specific.
Similarly Rab25, a protein that plays a critical role in translocating and recycling
integrin and other pro-migratory factors from endosomes to the plasma membrane have
contrary actions on cell migration. In esophageal squamous cell carcinoma (ESCC), Rab
25 was characterized as a tumor suppressor as diminished Rab25 expression was seen as
poor prognosis for esophageal cancer survival by enhancing migration and invasiveness
of cancer cells.129 Interestingly, it has also been shown that loss of Rab25 (function or
expression) increased turmorigenesis in mammary epithelial cells22. However, Rab25 is
also said to be an oncogene given its role in advanced stages of ovarian and breast
cancers and is linked to an increase in malignancy and migration of the epithelial cells by
modulating cell proliferation (both anchorage dependent and independent cells),
trafficking of integrin and suppressing apoptosis24. Specifically, Rab25 promotes cell
survival by increasing PI3K signaling through the interaction with the Rab-coupling
protein which in turn sustains the recycling of both EGFR and the fibronectin receptor
(integrin α5β1). It was determined that Rab25 accelerates cell migration by actively
moderating the recycling of integrins via the chloride intracellular channel protein 3
where this process is required in the freeing of the cell’s rear in cell migration and
invasion33.
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Both Rab25 and Rab11 overexpression augmented the pace of cell migration by
affecting small-scale fast recycling within the tips of the cell and basal long-distance
transport from the rear end to the front of the migrating cell basal long-distance transport
from the rear end to the front of the migrating cell respectively in HeLa and MDA-MB
231 cell lines69.
A GTPase essential for early endosomal formation and trafficking, Rab5, is involved
in lamellipodia formation and actin remodeling in response to growth factor stimulation
105,124

and this may be attributed to tyrosine signaling and subsequent activation of Ras

and Rab5 GAPs10,76.
Rab5 is expressed differentially in cancer cells where Yu et al. identified Rab5a as a
potential major factor in the transformation of tumor cells in human lung
adenocarcinoma, to an aggressive phenotype where overexpression of Rab5a was
associated with increasing metastatic capacity.151 The loss of Rab5a expression in HeLa
and SiHa cells significantly suppressed or abrogated cancer cell motility and also downregulated Rho A expression80 whereas Rab5a overexpression elevated the proliferative
activity of ovarian cancer cells155.
Studies in flies (Drosophila) and mouse neurons have shown that cell migration can be
mediated by endocytotic and trafficking mechanisms and dependent on Rab5 and Rab11
expression in epithelial cells68,118. Migration of cells in hepatocellular carcinoma was also
dependent on VEGF/PDGF (platelet derived growth factor) and EGFR mediated tyrosine
kinase endocytosis via Rab5

44

, hepatitis B induced Rab5 expression

119

and Rab1162,63.

Actin remodeling and cell migration are dependent on Rac activity which is trafficked by
Rab5 and affects the internalization of integrins during cell migration130,152.
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Lysosome trafficking is an important feature of the endocytic pathway particularly in
the degradation growth factor receptors and / or ligands and is regulated by Rab7125,140.
Disruption of the endocytic pathway in EGF mediated signaling in cancer cells can be
rescued by the activation of the autophagy and lysosomal pathway. A tumor suppressor
and Bax family member, Bif1, led to the recruitment of Rab7 to the early endosome and
facilitated the loss of cell migration of breast cancer cells by directing the degradation of
the EGFR114.

Rabs

Cancer Type

Rab4a
(invasion)

melanoma

Rab5a
(invasion)

cervical, breast

Rab5a
(migration)

hepatocellular
carcinoma, breast

Rab7
(invasion)

liver, prostate

Rab7
(migration)

breast, liver

Location

Cell Function

plasma membrane

protein transport

Effect on Cell
Migration or
Invasion
secrete
procathepsin-L,
translocates furin

Plasma membrane,
Early endosome,
Melanosomes

Fusion of PM to
EE, protein
transport

down-regulation of
integrins, Rac1,
CDC42, reduction
in number of
lamelipodia,
transport of MT1MMP and β3
integrin

plasma membrane,
early endosome

Translocation of
surface receptors
to late endosome

lamellipodia
formation and
actin remodeling in
response to growth
factor stimulation

Late endosome,
Lysosome,
Melanosomes

Late endocytic
transport

late endosome,
lysosome

exocytosis, late
endosome
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decrease protease
secretion

Refs

9

43,81

21,45,89,119,146

125,140

114,140

Rab8
(invasion)

lung adenocarcinoma

plasma membrane

vessicle trafficking

secretion and
cleavage of (MT1MMP

Rab11 (a,b,c)
(invasion)

breast, colon, lung,
ovarian, renal,
endometrial, prostate,
bladder and carcinoid
types

recycling endosome

Rab11 (a,b,c)
(migration)

breast, colon, lung,
ovarian, renal,
endometrial, prostate,
bladder and carcinoid
types

recycling endosome

Rab23
(invasion)

gastric cancer

Plasma membrane

vessicle trafficking

Rab25
(invasion)

colon, ovarian, head
and neck

apical recycling
compartment

integrin recycling

Rab25
(migration)

breast, pancreatic ,
ovarian

apical endosomes

integrin recyling

Rab27a,b
(invasion)

glioma, breast, liver

Plasma membrane,
melanosomes

exocytosis

secrete IGF-2,
MMP2 activation

Rab31
(invasion)

metastatic breast

Plasma membrane,
transgoli network

anterograde
transport

reduced adhesion
to extracellular
matrix proteins

50

Rab35
(migration)

breast, brain

sorting and recycling
endosome tubules

recycling

activate Rho
GTPases, actin
dependent
protrusions,
increase recycling
rate

3,28,157

Long loop
recycling

down regulates Ecadherin

long loop recycling

stabilization of
microtubules

16

150,156

20,48,69

60

recycles integrins
to psuedopodial tip
of invasive cells,
interact with
CLIC3 (chloride
intracellular
channel protein 3)
to recycle integrins
from late
compartment to the
rear of migrating
cells
sustained recycling
of intergrin and
growth factor
receptors

5,24,73

22,24,33,69,129

32,56,94,136,144

Table 1: Papers demonstrating some of the Rab GTPases including their function in
the promotion of cell invasion of tumor cells.
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1.4.3. The Role of Rab GTPases in Cell Invasion
Cancer cells attain an array of invasive and malignant phenotypes which are tumor
and/or site specific
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and involve a variety of Rab proteins that have been implicated in

the transition to metastasis where tumor cells become invasive and penetrate the basal
cell membrane and the ECM. These tumor cells secrete an array of proteases such as
MMPs, induce the compromised basement membrane to further release more proteases
such as collagenase and growth factors, thereby allowing cancer cells to breach the basal
membrane and migrate to distal sites. For example, it has been ascertained that Rab8
facilitates cell invasiveness in breast cancer cells at peripheral invasive structures16.
Further evidence of Rab7 as possible tumor and metastasis suppressor was illustrated
by Steffan et al125. Silencing of Rab7 expression has a diminutive effect on invasion and
when Rab7 was present, lysosomes were directed away from cell surface, thereby
decreasing protease secretion and metastatic capacity of prostate cancer cells125.
Rab7 has also been associated with MT1-MMP secretion and the promotion of cell
migration and invasion, where the dominant-negative mutant of Rab7 impairs both
processes 140. On the other hand, early stage melanomas promoted tumor progression via
Rab7 regulation of the lysosomal pathway, where high expression of Rab7 was an
indicator of the high metastatic risk (increased proliferative and invasive outcome) in
patients4. The contrary role of Rab7 may be attributed to cancer type, stage and specific
growth factor stimulus.
Under hypoxic conditions within the tumor microenvironment, Rab11 maintained the
stabilization of microtubules via the inactivation of GSK3-B and possible down
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regulation of E-cadherin, which led to an increase of cell invasion of breast cancer
cells150,156.
Caswell and colleagues established that Rab25 interaction with α5β1 integrin was
essential in ovarian epithelial tumor cell invasion into a 3 dimensional (3D) fibronectinenriched ECM and may additionally regulate MMP-dependent regulation16,20. Rab
coupling protein (RCP), an effector of Rab11 and Rab25, acts as an oncogene as it
promotes breast cancer transformation154. It is also purported that the invasive potential
of cancer cells is augmented in RCP mediated recycling and signaling of the EGFR and
integrin, downstream of a mutant form of p5396.
Poor prognosis in invasive breast cancers are associated with Rab27 a and b isoforms,
which are secretory GTPases that control vesicle exocytosis and secrete critical
proinvasive growth regulators into the tumor microenvironment. Inhibition of Rab27
activity reduced tumor growth and dissemination of lung carcinoma in response to
neutrophil mobilization that were in turn, dependent on Rab27 exosomal secretions13.
In primary hepatocellular carcinoma and lymph node metastasis, Rab27b is overexpressed
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, and in ER+ breast cancer, Rab27b activates MMP2 through heat shock

protein (Hsp) 90a secretion and stimulate invasion of breast cancer cells56,94. Rab27a is
involved in the exocytosis of endocrine cells and conferred an invasive and metastatic
phenotype by inducing the secretion of IGF-2 in breast cancer cells136.
The rate of IGF-2 secretion by Rab27 influenced the expression other growth factors
such as VEGF into the tumor microenvironment, as well as MMPs, such as MMP-9,
cathepsin D and the cyclin dependent kinases (CDK16)136. It was also suggested that
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Rab27 may act as an oncogene given its regulatory role of invasive growth and metastasis
in breast cancer cells and association with poor prognosis in humans56.
Like a few other Rab GTPases, such as Rab25, Rab27 have dual roles in
tumorigenesis and can be said to be context dependent. While the studies outlined
indicate a pro-tumorigenic and metastatic role of Rab27, a study by Li et al indicated that
Rab27 may possess more anti-tumor characteristics and demonstrated in a

mouse

model in vivo, that immunization of exosomes derived from Rab27a-overexpressing
cells suppressed tumor growth. Analysis of the mice spleens also revealed high levels of
type 1 cytokines, interleukin-2 (IL2) and IFN-y, in response to Rab27 generated
exosomes. These cytokines are crucial in the regulation of anti-tumor immunity79.
Rab23 also influences cell invasion in two distinct tumor types within gastric cancer,
where silencing of Rab23 abrogated such activity60. On the other hand, Rab31
overexpression engendered a shift from a highly invasive capacity to a less invasive and
highly proliferative phenotype in an experimental mouse model50.
Rab4 has also been implicated in the secretion of procathepsin-L, another significant
protease required in the modulation of the tumor microenvironment where suppression of
Rab4 expression led to a reduction of tumor mass.9 Growth factor stimulated breast
cancer cells overexpressing Rab5a affected Rab4 and RABENOSYN-5-dependent
endo/exocytic cycles in the ferrying of the matrix protease, MT1-MMP and β3 integrin43.
This trafficking cycle produced a chemotactic dependent invasive and proteolytic
mesenchymal response in breast carcinoma cells in vitro and in vivo43. Under hypoxic
conditions, increased cell invasion of tumor cells was also mediated by Rab4 dependent
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recycling and translocation of furin, which interacts with the cytoskeletal protein filamin
A at the cell surface.7

1.5. Conclusion
As the role of growth factor driven endocytosis in metastasis is slowly being
characterized, part of the struggle that currently exists involves the correct identification
of the crucial endocytic molecules that may be potential therapeutic targets in cancer
treatment. These may include but not limited to Rab5, and its effectors the GEFs such as
Rab interactor 1 (RIN1) and GTPase Activating Proteins (GAPs). As outlined lined
above, there is a paucity of research specifically regarding the relationship between Rab
GTPases and growth factors, particularly IGF-1, in cancer cell migration and invasion.
Whilst most Rabs are currently not considered to be oncogenic, there is growing
evidence that may suggest otherwise. Endocytosis is an indispensable signaling
mechanism in growth factor induced signaling, it is worth considering the early factors
such as Rab5 that exert a great influence on intracellular trafficking and also as a
coordinator in the crosstalk amongst signaling pathways in the propagating and
promoting metastasis (Fig 2).
Further description of Rab function in cancer cell metastasis would be beneficial as
these Rabs can be prospective biomarkers in determining cancer stage and outcome
prognosis. This opens the doors to the development of new therapeutic methods to target
these necessary proteins such as siRNA or peptide manipulations that can selectively
affect Rab effectors.
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1.6. Thesis Overview
This project aims to examine the trafficking and signaling pathways involved in the
progression from dormant tumor cells to aggressive invading cells via Rab5 GTPase
activity and interaction with IGF-1R, and subsequent downstream signal transduction
pathways. The hypothesis is that Rab5 GTPase activity is one of the key elements in
proliferation, migration and invasion of cells in breast cancer mediated by the IGF1R. Therefore, specific aims were designed to address this hypothesis.
For the Aims, it was:
(I) to determine whether small Rab GTPases mediate phenotypic changes in
the promotion of proliferation, migration and invasion activities in breast cancer cells
in the presence of IGF-1
(II) to elucidate the signaling mechanism induced by IGF-1 via Rab5
function in modulating malignancy of breast cancer cells
(III) to examine the role of Rab5-Guanine Exchange Factors (GEFs)
in proliferation and migration of breast cancer cells induced by IGF-1.
This thesis is divided into 5 chapters.
Chapter 1 is the INTRODUCTION and literature review. The content of this chapter has
been submitted for publishing and is currently under-review.
Chapter 2 elucidates the importance of Rab5, early endocytic membrane protein, as a
potential mediator of tumorigenesis and metastasis. The Rab5 activity was shown to be a
modulator of cells invasion and migration of non-aggressive breast cancer cells, MCF7 in
response IGF-1 stimulation. Further analysis revealed that the guanine exchange factor
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(GEF) that interacts with Rab5, Rin1, also promotes cells migration and invasion of
tumor cells.
Chapter 3 examines the suppression of the aggressive potential of the highly metastastic
breast cancer cell line, MDA-MB231 in response to IGF-1 and normal growth media.
Over-expression of the inactive mutant form of Rab5, Rab5:S34N, impaired the invasion
and migratory activity of aggressive breast cancer cells. Rin1 over-expression also
mediated a highly aggressive phenotype, while the mutant abrogated cell invasion and
migration.
Chapter 4 reveals the effect of inhibition of the IGF-1 receptor and early endocytic
pathway on cell migration and invasion in MCF7 cells. This study also demonstrates that
these inhibitors affect downstream signaling proteins and genes: the metalloproteinase
MMP9, Rab5a and MAPK and PI3K signaling pathways
Chapter 5 summarizes the relevance and significance of the above research with future
possibilities resulting from this study.

1.7. Figures
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Decrease in cell adhesion molecules;
Rab5 dependent endocytosis of E-cadherin
Up-regulation of mesenchymal markers: N-cadherin, vimentin, smooth
muscle actin
Proteolytic driven
Integrin trafficking via Rab5 and Rab4 leading to FA disassembly
Growth factor dependent

Activation of Rac1/RhoA GTPase switch
Spherical transformation and deformation
ECM attachment and protease independent
(pass through existing interstitial gaps)
Growth factor independent or dependent

Illustrated by Meifung Su

Figure 1. EMT-mediated invasion and amoeboid invasion in cancer metastasis.
TAMs secrete cytokines and growth factors (EGF, TGF, HGF) and primary tumor
cells respond to growth factor stimulation. These cells (dark in color) undergo EMT
and invade and migrate into blood or lymphatic circulation. Some tumor cells may
invade via AT by morphological conformation to spheroids and pass through preexisting gaps in ECM. (EMT: epithelial-mesenchymal transition, MAT:
mesenchymal-amoeboid transition, AT: amoeboid transition, TAMs: tumor
activated macrophages)
IGF-1R as a possible target in tumor progression and metastasis
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Illustrated by Meifung Su

Figure 2. Illustration of the possible role IGF-1 plays in mediating metastasis in breast
cancer cells. IGF-1 ligand binds to IGF-1 receptor. The activated receptor is internalized;
Rab5 is recruited leading to the formation of the early endosome and subsequent launching
of the downstream endocytic machinery and MAPK pathway. The IGF-1R is later shuttled
back to the plasma membrane via the recycling endosome (RE), or to the lysosome through
the late endosome (LE). It is known that IGF-1 can also lead to the transactivation of the
EGFR 113, internalization of the EGFR and subsequent degradation of the receptor.
Activation of the MAPK pathway led to the transcription and secretion of
metalloproteinases such as MMP2 and MMP9, degradation of the basement membrane,
actin polymerization and reorganization of integrin receptors.
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CHAPTER 2.
Insulin-like Growth Factor-1 induces Migration and Invasion via Rab5 Activation
This chapter demonstrates the atypical non-invasive breast tumor cells (MCF7) acquire
an aggressive phenotype, thereby becoming more proliferative, motile and invasive in
response to IGF-1. Most importantly, early endocytosis of the IGF-1R regulated by Rab5
and its GEF RIN1 is implicated in this transition of breast cancer cells.
2.1 Abstract
Cell invasion, proliferation and migration are classic indicators of metastasis. Growth
factors, while important for normal cellular processes, are also pro-metastatic. In this
study, it was determined that invasion and migration in non-invasive MCF7 cells was
regulated by growth factors via Rab GTPases. It was also indicated that the invasive and
migratory properties of breast cancer MCF7 cells upon growth factor stimulation were
abrogated in cell lines that only expressed the inactive (GDP-bound) form of Rab5
irrespective of growth factor stimulation. The invasive potential of breast cancer MCF7
cell lines expressing the Rab5WT and active (GTP-bound) form of Rab5 mutant
(Rab5:Q79L) were noticeably greater when exposed to growth factors. In addition, we
observed that Rab5 was activated in cells incubated with IGF-1 in a time and
concentration dependent manner. Therefore, it can be concluded that Rab5 activation
plays a crucial role in cell invasion, proliferation, migration particularly in response to
growth factor stimulus.
2.2 Introduction
Cell migration and invasion are key components of metastasis where the atypical
epithelial cells have acquired phenotypic changes that mediate the spread of the cancer to
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distant tissues and organs. These processes are highly regulated and controlled by the
expression and localization of specific cell surface receptors, such as integrin receptor,
EGFR, IGFR; the reorganization of cytoskeletal elements; and the directed trafficking of
molecules required for cell signaling and adhesion

1,39,49

. Therefore it unsurprising that

cancer cells hijack and utilize these important cellular and biological functions ensuring
the malignancy and spread of the disease to distal sites.
Trafficking of signaling molecules and ligand growth factors are regulated by the Rab
family of proteins. These small monomeric GTPases play important regulatory roles in
vesicle formation and transportation from plasma membrane to various organelles within
the cell through the recruitment of small factors that include phosphatases, kinases and
docking , adaptor proteins as well as actin filaments and microtubules in cell migration
and mitosis 50.
Given the myriad of functions that Rab proteins regulate, it is unsurprising that there is
a marked interest in Rab GTPase function and expression in tumor progression. The Rab
proteins have been specifically linked to the deregulation of several signaling pathways in
several cancers and also been implicated in the promotion of abnormal migratory and
invasion of epithelial cells in tumor progression55,58,63. For example, Rab25 is purported
to be an oncogene given its role in advanced stages of ovarian and breast cancers and is
linked to an increase in malignancy and migration of the epithelial cells by modulating
cell proliferation (both anchorage dependent and independent cells), trafficking of
integrin and suppressing apoptosis6. The silencing of Rab35 inhibited cell migration in
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MCF7 breast cancer cells67, while Rab11 and Rab27 facilitate an invasive phenotype and
poor prognosis in breast carcinoma15,62,64.
Rab5, a GTPase essential for early endosomal formation and trafficking, is involved in
lamellipodia formation and actin remodeling. These physiological changes are in
response to growth factor stimulation, the recruitment of Rac1 guanine-nucleotideexchange factor (GEF) Tiam1 to early endosomes36,47 and these changes may be
attributed to receptor tyrosine kinase (RTK) signaling and subsequent activation of Ras
and Rab5 GAPs4,27. Rab5a is expressed differentially in cancer cells where Yu et al.
identified Rab5a as a potential major factor in the transformation of tumor cells in human
lung adenocarcinoma, to an aggressive phenotype where overexpression of Rab5a was
associated with increasing metastatic capacity63.
Inulin Growth Factor -1 Receptor, a RTK, is involved in cell survival and proliferation
of both normal and malignant phenotypes60. Insulin Growth Factor signaling is initiated
by the binding of the IGF-1 or IGF-2 ligand to the IGF-1R/ IGF-2R and the subsequent
autophosphorylation of tyrosine residues of specific cytosolic kinase domains. The
activated receptor transduces this phosphorylation activity to IRS and Shc adaptor
proteins, and starts a signaling cascade that involves the MAPK and PI3K intracellular
signaling pathways that regulate cell survival and proliferation. RTKs can be internalized
through two principal pathways: clathrin coated pits or caveolae. The IGF-1R is
internalized via both pathways7 and this may have a significant pathological effect in
tumor progression.
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The inherent relationship between Rab5 and IGF-1 in metastasis is more than implied
despite the paucity of data establishing a clear link. As it currently stands, research have
both alluded to IGF-1 involvement in endocytic pathway and the consequent activation of
down signaling molecules

16,42

. The present study investigated Rab5 activity in response

to IGFR activation in breast cancer.
Here, it has been determined that Rab5 expression was closely related with increased
cell migration and invasion of MCF7 breast cancer cells. Furthermore, the guanine
exchange factor, the Rab5 interfering 1 (RIN1), also induce breast metastasis through the
enhanced endocytosis of the IGF-1R.
2.3 Materials and Methods
2.3.1 Cell Culture and Materials:
The MCF7 cells were grown in Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 10% (w/v) fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin, and 100 μg/ml of streptomycin. The antibodies for EEA-1 and Rab5 were
purchased from Cell Signaling Technology (Beverly, MA). RIN1 antibodies were from
Abcam Inc. and secondary antibodies were obtained from Jackson ImmunoResearch
Laboratories (West Grove, PA). IGF-1 was purchased from Novus Biologicals (Littleton,
CO) .Other chemicals were obtained from Sigma unless otherwise stated.
2.3.2 Construction of recombinant pMX-puro retroviruses and cell lines
As previously described, the cDNAs of Rab5 and RIN1 were subcloned into the pMXpuro vector 3.Transfection of 60% confluent PhoA cells was perfomed using Fugene
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(Roche) and the virus harvested after 48hrs post-transfection. MCF7 cell line was
infected with the retrovirus tagged with green fluorescent protein (GFP) and Rab5, RIN1
and control cell lines were generated and selected after 72 hrs.

2.3.3 EEA1 pull-down assay
The MCF7 cells were lysed using a lysis buffer containing 20 mM HEPES (pH 7.5), 100
mM NaCl, 1 mM DTT, 5 mM MgCl2, 5% (v/v) glycerol and 1% (v/v) Triton-X-100
supplemented with 1 mM PMSF. Lysates (1 ml) were then incubated with 100 μl of
glutathione beads containing ~10 μg of GST-EEA1 at 4°C while rocking for 1 hr. After
incubation, the beads were washed three times using the lysis buffer. The pull-downs
were subjected to SDS-PAGE and analyzed by immunoblotting using an anti-Rab5
antibody.
2.3.4 Cell Migration and Invasion Assays
Migration of MCF7 cell lines was measured using Transwell inserts (8 μm pores,
Trevigen, MD). Cells suspended in serum-free and phenol free DMEM and applied to the
upper chamber. Serum and phenol free media with or without IGF-1 added to the lower
chamber and the plate incubated at 37oC for 24hrs. Non-migrated cells in the upper well
were removed and the membranes were fixed and stained using 0.01% crystal violet. The
membranes were either photographed or counted under a light microscope (×100) or the
dye extracted and the absorbance reading obtained using a spectrophotometer.
For the Matrigel invasion assay, transwell inserts coated with 0.5 mg/ml Matrigel (BD
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol
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free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and
phenol free media with or without IGF-1 added to the lower chamber and the plate
incubated at 37oC for 24hrs. Subsequently, the membranes were fixed, stained, and
photographed as above or absorbance readings acquired.
2.3.5 Cell Proliferation Assay
The MCF7 cell lines expressing Rab5 WT, the inactive form of Rab5 (Rab5:S34N),
the active form Rab5 (Rab5:Q79L), RIN1 and its isoforms, RIN2 and RIN3, and
RIN1:R94A mutant or

vector clone were seeded in 96-well plates at a density of

25 × 103cells/well in 100 ml medium and incubated overnight. Cells were then serum
starved for 24hrs followed by treatment serum and phenol red free DMEM with or
without IGF-1 for 48 hrs. After, the MTT solution (5 mg/ml) was added to the plates and
the cells incubated at 37 °C for 4 hrs. The formazan, derived from MTT by living cells,
was dissolved in 10% SDS (150 ml per well), and the absorbance was measured at
595 nm. All MTT experiments were performed in triplicate and repeated at least 3 times.
2.3.6. Anchorage-Independent Growth Assay
Briefly, 1 × 103 cells of each cell line were suspended in 300μl of Dulbecco’s
Modified Eagle’s medium containing 10% calf serum and 0.35% SeaPlaque low-melting
temperature-agarose. These cells were plated over a 300μl layer of solidified Dulbecco’s
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were
allowed to settle to the interface between these layers at 37 °C. After 20 min, the plates
were allowed to harden at room temperature for 30 min before returning to 37 °C. 100μl
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of vehicle control or IGF-1 was added to wells and the plate incubated at 37 °C. The
plates were fed every 2–3 days. After 12-14 days, colonies were photographed under low
magnification (x10).

2.3.7 RNAi constructs and transfection
The

RNAi

directed

against:

mouse

RIN1

[5'-

UUAUACAUUUGCUUCACACCUAAGC-3'], was designed and synthesized by
Ambion (Austin, TX). A scrambled RNAi was designed as a control [5'CACCUAAUCCGUGGUUCAA-3']. Prior to RNAi transfection, MCF7 cells were plated
in growth medium without antibiotics at 30-50% confluency. RNAi (20 nM final
concentration) transfection was performed using Lipofectamine-2000 (Invitrogen,
Carlsbad, CA), as specified by Invitrogen. After transfection, cells were used either for
cell invasion and migration assays.
2.3.8 Statistical Analysis
All samples in this study were analyzed in duplicate and each experiment was repeated
three times. Values represent the mean ± SEM of three independent experiments. To
compare two groups, student’s t test was utilized. A p < 0.05 was considered as
statistically significant.
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2.4 Results
2.4.1 IGF-1 stimulation triggers the endocytic pathway by upregulating Rab5 activity.
It is known that Rab5 is a key molecule in insulin and growth factor endoyctosis and
signaling

3,5,16,22

. Furthermore, IGF-1 stimulation mediated the loss of surface IGF-1R

and formation of Rab11 endosomes in glial cells
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indicating the role of the endocytic

pathway in IGF-1 signaling. Given that Rab5 is required for early endocytic activity, the
possible role of Rab5 in IGF-1 signaling was investigated in breast cancer cells, by
preparing a stable cell line using a retroviral system in MCF7 cells. As described in the
Materials and Methods, the cells were infected with a retrovirus encoding GFP-Rab5
constructs. Stable cell lines over-expressing Rab5 were stimulated with a physiological
concentration of IGF-1.

Rab5 activation upon IGF-1 stimulation was examined by

precipitating the active or GTP-bound form of Rab5 with GST-EEA1 domain. After 5
mins of growth factor stimulation, the amount of GTP-bound form of Rab5 in cells
expressing Rab5WT was 5 fold compared to control (Figure 3). The data show that IGF-1
stimulation promotes the interaction between EEA1 and Rab5 of which the latter must be
in the active-GTP form. EEA1, a downstream effector of Rab5 is required to tether the
active GTP-Rab5 to the membrane and facilitate the fusion of the early endosome in the
trafficking of the activated receptor (Figure 3)5,31,46,51.
2.4.2 Increase in the proliferative and invasive capacity of IGF-1 stimulated tumor
cells is dependent on Rab5 activity.
Prior data have shown cell proliferation is dependent on Insulin receptor (IR)
activation via Rab5 activation in liver cancer cells
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16

. Rab GTPases act as regulatory

molecular switches where they hydrolyze the active bound form of GTP to the inactive
bound form thereby acting as molecular switches23 as they cycle between the active GTP
and inactive GDP bound forms24. Early endosome formation and receptor internalization
and trafficking is dependent on Rab5 activation38. Therefore, it was necessary to show
that non-aggressive breast tumor cells overexpressing Rab5:Q79L would augment cell
proliferation because of the rapid IGFR endocytosis.

Hence, it is unsurprising a

significant increase in cell proliferation was observed in GFP and Rab5WT in the
presence of IGF-1 breast cancer cells compared to vehicle control (Figure 4a). The cells
expressing the constitutively active mutant form of Rab5, Rab5:Q79L, had approximately
4.5 fold increase in cell proliferation when compared to GFP alone while the inactive
form GDP bound form, Rab5:S34N, had the opposite effect and inhibited growth.
Considering IGF-1 increased the proliferative capacity of the MCF7 breast cancer cells,
another experiment was designed to examine whether IGF-1 does indeed play a key role
via Rab5 activity in cell migration and invasion of tumor cells.
Within the tumor microenvironment, degradation of the extracellular matrix (ECM)
releases growth factors including IGF, and they incur a bi-directional response to tumor
cells growth factor secretion24,61. Both the migratory and invasive action of MCF7 cells
overexpressing Rab5WT (figures 4b and 4c respectively) was augmented in the presence
of IGF-1.
In cells overexpressing the constitutive inactive GDP bound form of Rab5,
Rab5:S34N, was significantly abrogated in both the vehicle control and IGF-1 stimulated
cells. Interestingly when the GTP bound form of Rab5, Rab5:Q79L, was overexpressed,
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migration and invasion of the MCF7 cells were greater than the rates of control cells in
the absence and presence of IGF-1.
The invasive potential of Rab5WT was pronounced when compared to those in the
migration assay (4 fold compared to 2.5), considering the cells must transverse a barrier,
specifically the basement membrane. This can be attributed to the degradation of the
ECM by secretion of proteolytic enzymes by the cancer cells and the subsequent release
of pro- migratory and invasive growth factors10 from the matrigel, which in turn stimulate
the MCF7 cells.
2.4.3. IGF-1 stimulates Rab5 activation in breast cancer cells overexpressing Rab5
specific GEFs
The switch from the inactive GDP to active GTP state of GTPases are enabled by
small proteins called guanine exchange factors (GEFs)35. The Ras interfering (RIN)
family of proteins has been recognized as the GEFs for Rab5 and each one (RIN1, RIN2,
RIN3) interacted preferentially to inactivated Rab544. RIN1 is known to interact with the
EGFR22 and IR17. The role of RIN1 in tumor progression is contrary at best, suggesting
that RIN1 expression in cancer progression can be growth factor and tissue specific2,9,14.
The MCF7 cells were transformed using a retrovirus system and selected for RIN1, RIN2
and RIN3. If RIN proteins were a requirement for the active Rab5 form, the pull-down
assay was performed to verify active Rab5 presence in cells overexpressing RIN1, RIN2
and RIN3 in response to IGF-1. Cells were incubated with IGF-1 for 5mins and the
amount of active Rab5 generated was quantified using SDS-PAGE after precipitating
with GST-EEA1 protein. IGF-1 led to more Rab5 activation in tumor cells over
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expressing RIN1 and RIN3 compared to the vehicle control. Though there was some
Rab-GTP bound form present in RIN2 expressing cells, it was significantly less in cells
overexpressing RIN1 and RIN3.
2.4.4. IGF-1 elicits a strong proliferative, invasive and migratory response in tumor
cells overexpressing Rab5 GEFs
On the basis of our results above, it was deduced that expression of Rab5 GEFs may
also induce cell proliferation and migration in breast cancer cells in response to IGF-1.
This activity is attributed to the GEF activity in switching Rab5 to the GTP bound form
and promoting proliferation in the breast cancer cells. Using the Boyden chamber as
described in the Materials and Methods, a 2-fold and 4-fold increase in cell migration
was observed in RIN1 and RIN3 cell lines respectively (Figure 6a). While RIN2
engendered an increase in migration in the presence of IGF-1, it was not much of an
alteration when compared to the control cell line. Both RIN1 and RIN3 also garnered an
augmentation of cell invasion in both cell lines (Figure 6b), with RIN3 having less
invasion of cancer cells compared to RIN1 and the GFP control. Like the Rab5:Q79L
mutant cell line, RIN1 cancer cells behaved more aggressively even when IGF-1 was
absent. Whether or not this is significant still needs to be ascertained but initially suggests
that Rab5 aberration may be key in metastatic progression.
To further establish the function of RIN1 in mediating pro-invasive response to IGF-1
in breast cancer cells, RNAi suppression of RIN1 expression was performed and the
invasive response quantified (figure 9c). Temporal silencing of RIN1 gene expression in
breast cancer cells significantly inhibited invasion of the cancer cells.
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2.4.5. IGF-1 fostered in vitro tumor formation in cancer cell and is dependent on Rab5
activation.
Tumor formation occurs pre- and post-metastasis where the initial tumor may acquire
anchorage independence and secondary tumor formation or re-colonization may be both
anchorage dependent or independent12. It is also important to note that as cancer cells
continue to feed and increase in size, cells on the perimeter are typically the first cells to
undergo changes and gain aggressive and highly motile tendencies. Most importantly, it
only takes one cell for a secondary tumor to develop.
Here, it was necessary to show that IGF-1 influences colony formation in breast tumor
cells, particularly through Rab5 activity. Cells overexpressing Rab5WT formed larger
and more colonies compared to the vehicle control (Figure 10a.) In cells with RIN1
overexpression (Figure 10b), it was surprising to observe that colony formation, while
greater in number and more pronounced in size in response to growth factor stimulation.
Colonies were also numerous and larger in the absence of IGF-1 when compared to the
control and even RIN3.
2.5 Discussion
Cancer cells become highly motile and invasive in response to small alterations in the
tumor microenvironment and hijack important cellular functions such as cell migration12.
In light of this behavior, endosomal trafficking in cancer, particularly in the propagation
of metastasis, is a major point of interest in cancer research. There is increasing evidence
that the early endocytic molecule, Rab5 GTPase, is a foremost player in cell
motility/migration of normal and cancer cells as reviewed by Stupack et al.58, and also
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engaged in lamellipodia formation and actin remodeling in response to growth factor
stimulation 37,48.
While Rab5 is expressed differentially in cancer cells, when overexpressed, it was
identified as a potential modulator of tumor cell transformation to aggressive phenotypes,
also indicative of its possible role in metastasis

63,66

. Additionally, Rab5 GTPases has

been characterized as an essential signaling molecule in response to growth factor
stimulation 3,5,16,22.
Here, it was demonstrated Rab5 had a critical role in the early phases of metastasis,
specifically affecting the migratory and invasive capacity of breast cancer cells. Yet it is
not fully determined that IGF-1 signaling is dependent on endocytic trafficking and may
spur the activation and recruitment of the active form of Rab5 from the cytosol to the
membrane.
Circulating IGF-1 levels are higher in breast cancer patients compared with normal
controls40 while high IGF levels are associated with increased risk of breast cancer in
pre-menopausal women

13

. IGF-1 ensures the survival and hyper-proliferative state of

cancerous cells. IGF-1 modulates cell proliferation by affecting changes in the apoptotic
signaling pathways. IGF-1R is found in all breast cancer cell lines regardless of estrogen
receptor status 8.
Notably, IGF-1 is known to stimulate the estrogen receptor (ER) in the absence of
estrogen itself, thereby allowing for more crosstalk between the IGF-1R and ER,
phosphorylation of the ER and increased synthesis of IGF-1R and ER transcripts19,29,52.
IGF-1R activation mediate and conformational change in Bad, a pro-apoptotic protein,
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which inhibited its interaction with the Bcl (anti-apoptotic) proteins and the subsequent
activation of the caspase chain thereby allowing transformed and pre-cancerous cells to
escape apoptosis and survive11,28,30.
Curiously, Rab5 has been shown to be a key regulator in caspase mediated signal
transduction and facilitates increased motility and survival of cancer cells56,57. This
suggests that in general, RTK internalization via Rab5, may also result in the increase of
caspase expression and sequestration of integrins to early endocytic compartments
suppressing apoptosis of cancer cells.
In the present study, the proliferative effect of IGF-1 on breast tumor cells was clearly
evident in the presence of the growth factor and positively correlated to Rab5 expression
(Figure 5a.). This may be attributed to modulation of apoptotic factors such as caspase-8
26,53,55

or down-stream activation of adaptor protein, phosphotyrosine interaction, PH

domain and leucine zipper containing 1(APPL-1) of which the latter has implications in
growth factor dependent Rab5 activation in ovarian cancer 66. Studies have intimated that
IGF-1 exerts a strong mitogenic and anti-apoptotic effect on cells and bolsters the prometastatic property of cancer cells by reorganizing integrin receptors and modulating the
E-cadherin/ B-catenin complex which in turn increases the migratory potential of the
cells 54,59.
These intracellular changes of the E-cadherin/ B-catenin complex increase MMPs
expression, disintegration of the ECM and release of growth factors and push tumor cells
to a mesenchymal phenotype59. Rab5 function in the migration and invasion of cells due
to IGF-1 induction of metastasis suggests that Rab5 mediates the internalization of the
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activated IGF-1R, either through a clathrin dependent or independent mechanism.
Specifically, cell migration was dependent on active Rab5 translocation to the plasma
membrane and formation of early vesicles as the inactive GDP bound form, Rab5:S34N,
suppressed the migratory aptitude of cancer cells. A similar pattern was established when
the invasive capacity of cancer cells was also investigated in response to IGF-1
stimulation. It was also noted that there was a strong migratory and invasive capacity of
tumor cells in the cells overexpressing the active Rab5, Rab5:Q79L, irrespective to IGF-1
stimulation. During metastasis, invading cancer cells acquire an autonomous trait where
they are less reliant on external growth factors and move in response to internal signaling
events and secretions. As acknowledged earlier, IGF-1 regulates the pro-survival
transduction pathway60, and it has been demonstrated that internal forces unleashed in
cancer cells may also be due to caspases, in a non-apoptotic role. This can potentiate
migration and invasion in tumor cells and is reliant on Rab5 activation 58.
Rab5 activity status seems to be critical in facilitating IGF-1 induced breast cancer
cell migration and invasion, yet some studies imply that Rab5 may instead be a tumor
suppressor. In part, this may be attributed to overexpression of a few of the GEFs for
Rab5, the RIN family of proteins. Specifically it has been suggested that RIN1 may be a
breast cancer tumor suppressor gene14,34. However, this study suggests otherwise, that
over-expression of RIN1 and RIN3 fostered an increase in migration and invasion of the
cancer, with RIN1 eliciting a slightly larger rise in the metastatic potential of the cells
compared to RIN3. This also implies that RIN1 expression instead, may be a key
prognostic marker of cancer metastasis and progression9,45.
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RIN1 is recognized as a regulator of Rab5 as it possesses three features needed in
early endocytic signaling; Src Homology 2 (SH2), Rab5-GEF and the Ras binding
domains 18. Though not shown, RIN1 interaction with the IGF-1R via the –SH2 domain
is a possible precursor for the activation of ERK and PI3K/Akt signaling pathways.
Due to the highly homologous relationship between IGF-1 and insulin and their
receptors, it is therefore likely that RIN1 would also regulate IGF-1R internalization and
promote migration and invasion of breast cancer cells20. Furthermore, IGF-1 can also
trans-activate other growth factor receptors like the EGFR and of which the latter has
been described in studies characterizing the EGFR relationship with RIN1 2,25,43.
Hence, it can be deduced that this is another mechanism that IGF-1 influences cell
migration, proliferation and invasion of cancer cells. In Figure 9c, RIN1 as a principal
switch in cancer cell metastasis was substantiated when depleted RIN1 levels negated the
tumor cell invasion alluding to two possible roles of RIN1 in growth actor signaling in
metastasis:
1. Action on Rab5 leading to its active form;
2. Thus, there is direct Rab5 activation and interaction with the cystolic tail of the IGF1R ensuring the internalization of receptor and subsequent activation of the
intracellular signaling pathways.
Jozic et al. showed that RIN1 facilitated the fusion of the insulin receptor to the early
endosome and was Rab5 dependent21. Other Rab5 effectors such as Rabaptin are known
to interact with the platelet-derived growth factor beta receptor (PDGFbetaR) and led to
deleterious

myleoproliferative

phenotype
60

in

mice32.

Rabaptin

also

functions

synergistically with another adaptor for Rabex5 GEF to activate Rab5 and promotes
early endosomal fusion
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and receptor internalization41. Whether these Rab5 effectors

are also involved in IGFR trafficking in tumor progression has yet to be investigated.
In summary, this study clearly shows that Rab5 and well as its GEFs, RIN1 and
RIN3, are central players in metastasis of cancer cells especially in the trafficking of the
activated IGFR. How Rab5 and RIN1 specifically regulates invasion in response to IGF1 must still be investigated.

Mendoza et al. suggested that Rab5 modulated focal

adhesion kinase activity and matrix metalloproteinases (MMPs) in cancer cells

33

, yet

little information is available as to IGF-1 role in facilitating this intracellular response.
Here, it is shown that the change to an aggressive and invasive phenotype of noninvasive tumor occurred through Rab5 and RIN1 recruitment and activation in
trafficking of the IGF-1R upon IGF-1R stimulation.
2.6 Figures
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Figure 4. (a) IGF-1 enhances cell proliferation via Rab 5 activation. Cells expressing
either GFP or GFP-Rab5:WT and its mutants were incubated in the absence or in the
presence of IGF-1 in triplicate. Cell proliferation was assessed after 48hrs incubation
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with vehicle or IGF-1 of cell culture, using the MTT proliferation assay (Sigma). Briefly
after the incubation period, cells were added with 100 μL of 5 mg/mL thiazolyl blue
tetrazolium bromide (Sigma, St. Louis, MO) solution/well and were incubated further for
4hrs in a humidified atmosphere (37°C in 5% CO2). The absorbance was measured at
560 nm in a microplate reader. Cell proliferation was expressed as the mean percentage
absorbance compared to vehicle control ± percentage SD for three independent
experiments. In Figures 4(b) and 4(c), IGF-1 mediates cell invasion and migration in
MCF7 cells via Rab5 activation. Cells were plated in a boyden chamber with or without
basement extract membrane. Treatment groups were IGF-1 or vehicle control and cells
were incubated at 37oC for 16h. Crystal violet staining was performed and the dye
extracted and the OD measuring using a plate reader at 595nm. Cell migration and
invasion absorbance reading were expressed as relative OD to control ± SEM for three
independent experiments where (*) denotes p<0.05, (**) is p<0.01 and (***) is p<0.005.
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Figure 5. IGF-1 stimulates Rab5 activation in breast cancer cells overexpressing
Rab5 specific GEFs MCF7 cells expressing the GEFs RIN1, RIN2, and RIN3 were
stimulated with IGF-1 or vehicle control for 5 mins and assayed for active GTP-Rab5 as
described in Materials and Methods. Data represent the mean ± SEM of three
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independent experiments. (*) represents statistically significant difference from control
group (P<0.05); n.s. = no significance
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Figure 6. The Rab5 GEFs mediate cell invasion and migration in MCF7 cells via
Rab5 activation. As previously outline in Figure 4, tumor cells expressing GFP and the
Rab GEFs; RIN1 and RIN3. Cells were placed in a Boyden chamber with or without
basement extract membrane (figures 6a and 6b respectively) Treatment groups were IGF1 or vehicle control and cells were incubated ta 37oC for 16h. Crystal violet staining was
performed and the dye extracted and the OD measuring using a plate reader at 595nm.
Cell migration and invasion absorbance reading were expressed as relative OD to control
± SEM for three independent experiments. (*) represents statistically significant
difference from control group (P<0.05)
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Figure 7. Rab5 and its GEFs promote colony formation in IGF1 stimulated breast
cancer cells. Each cell line was plated over a 300ul layer of solidified Dulbecco’s
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were
allowed to settle to the interface between these layers at 37 °C. 100ul of vehicle control or
IGF-1 was added to wells and the plate incubated at 37 °C. The plates were fed every 2–3
days. After 12-14 days, colonies were photographed under low magnification (x10). Each
cell line was done in triplicate with data represent the mean ± SEM of the three
independent wells. (*) represents statistically significant difference from control group
(P<0.05); (**) is (P<0.01) and (***) is (P<0.001)
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CHAPTER 3.
Requirements of Rab5 Activity in Highly Invasive Breast Cancer Cell Lines.
This chapter sought to elucidate the functional role of Rab5 in facilitating cell migration
and invasion in invasive breast cancer cells.
3.1 Abstract
Rab5 expression in cancer has been associated with diseases progression and prognosis.
Growth factor-directed cell invasion and migration was dependent on Rab5 activation in
non- invasive breast cancer cells. However, hardly any data are available regarding the
role of Rab5 in invasive cells in the absence and presence of growth factors.
In this study, it is reported that the invasive and migratory properties of the triple
negative highly invasive breast cancer cell line, MDA-MB-231, were abrogated in cells
expressing the inactive (GDP-bound) form of Rab5 irrespective of growth factor
stimulation, while the invasive potential of breast cancer cell lines expressing the
Rab5:WT and the active form of Rab5 mutant (Rab5:Q79L) were noticeably greater.
Rab:S34N significantly suppressed the migratory and invasive capacity of MDA-MB-231
cells. Interestingly, expression of RIN1, a Rab5 GEF, increases invasion and migration of
MDA-MB-231 cells even in the absence of growth factors. In contrast, RIN1:R94A
mutant partially mitigates both processes. Hence, it is reasonable to speculate that cell
invasion and migration, a process that typically involves activation of IGF-1 receptor, can
be intracellularly regulated without intervention or activation of growth factor receptors,
but elicits a greater invasive response if growth factors are present.
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3.2. Introduction
Over the last few years, Rab proteins have been specifically linked to the deregulation
of several signaling pathways in a variety of cancers and also been implicated in the
promotion of abnormal migratory and invasion of epithelial cells in tumor progression
5,6,25

. Rab5, a member of this prolific Rab GTPase family, has generated a lot of interest

in cancer development and progression given the myriad of cellular functions that the
protein regulates. Rab5 is involved in vesicle formation, early endosome docking and
fusion, translocation from plasma membrane to various organelles within the cell through
the recruitment of small factors that include phosphatases, kinases, adaptor proteins as
well as actin filaments and microtubules in cell migration and mitosis 29.
Endocytosis is an indispensable signaling mechanism in growth factor induced
signaling, it is worth considering the early factors such as Rab5 that exert a great
influence on intracellular trafficking and also as a coordinator in the crosstalk amongst
signaling pathways in cancer pathogenesis. Within cancer biology, recent studies have
pinpointed Rab proteins as a possible controller of the metastatic expression of cancer
cells with influence on the degree of malignancy in lung and stomach cancer.
Based on the data derive from the first Aim, it was demonstrated that Rab5 activity
drives the metastatic potential in non-invasive tumorigenic breast cancer cells. Whilst
Rabs are currently not considered to be oncogenic, there is growing evidence that may
suggest otherwise17,22,28,36,38,39.
Insulin Growth Factor 1 (IGF-1) is pathologically critical in cancer development and
progression. Epidemiological studies has implicated free IGF-1 serum levels as a risk
factor for the development and progression of breast, prostate, colon, and lung cancer
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11,23

. Davison et al. has shown that triple negative highly invasive breast cancer cells were

highly sensitive to IGF-1 which promoted cell proliferation and survival 7. While there is
a plethora of data regarding the IGF-1 and its receptor in cancer metastasis, there is a
paucity of research specifically regarding the relationship between Rab GTPases and
IGF-1R in cancer progression.
Interest has been building regarding the dynamic interplay between endocytosis of
receptor tyrosine kinases (RTK) and signaling. During endocytosis, receptors are active
within the endosomes16 thereby supporting the theory that membrane trafficking is a
regulator in growth factor signal transduction. Metastatic factors such as hepatocyte
growth factor (HGF), epithelial growth factor (EGF), transforming growth factor β (TGF
β) and insulin growth factor 1 (IGF-1) are known to activate the endosomal pathway and
the mechanisms can be analogous at key junctions thereby promoting a migratory
response in tumor cells.
The role of clathrin-mediated endocytosis in EGF-directed chemotactic invasion of
breast cancer20 and internalization and co-localization of the IGF-1R with clathrin and
caveolin-1 in Ewing sarcoma cells18 denoted the relationship of endocytosis and RTK
trafficking in cancer. Other studies have established that IGF-1R is also localized in the
nucleus in prostate, renal and breast tumor cells after translocation from the cell
surface1,and Rab5a is characterized as a significant molecule in ovarian cancer upon EGF
stimulation40.
On the other hand, Rab5c has been implicated in EGFR signaling by affecting integrin
recycling and triggering cell invasion in some breast cancer cells22. Hepatocyte growth
factor receptor (Met) trafficking requires Rab5 and facilitates focal adhesion turnover,
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actin remodeling and sustained MAPK signaling thereby underscoring its role in
tumorigenesis, cell migration and invasion12.
Rab5-dependent IGF-1-signaling may a noteworthy aspect of cancer metastasis based
on earlier results. Given that the potential role IGF-1R trafficking in invasive breast
cancer is unknown, this study sought to explore and highlight the possible role of early
endosomal trafficking in mediating phenotypic changes in the promotion of proliferation,
migration and invasion activities of invasive breast cancer cells in the presence of IGF-1.
3.3. Materials and Methods
3.3.1. Media and Antibodies.
Trypsin and DMEM medium were purchased from Fisher Scienific. Basement extract
membrane was obtained from Trevigen (Gaithersburg, CA). The following antibodies
were used for Western blotting: Rab5, FAK, MMP-2, MMP-9, anti-ERK, cJun, p38, Akt,
phospho-ERK, phospho-cJun, phospho-p38, phospho-Akt, GAPDH , (Cell Signaling
Technology, Danvers,MA).

Anti-mouse, and anti-rabbit IgG peroxidase-conjugated

secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West
Grove, PA).

3.3.2. Cell Culture.
The human breast cancer cell line, MDA-MB-231, was obtained from the American
Type Culture Collection (ATCC; Manassas, VA, USA). Cells were maintained in DMEM
medium supplemented with 10% fetal calf serum, 2 mM glutamine, and antibiotics (100
U/mL penicillin and 100 lg/mL streptomycin) at 37oC in a humidified atmosphere of 5%
CO2.
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3.3.3. Construction of Recombinant pMX-puro retroviruses and cell lines
As previously described, the cDNAs of Rab5 and Rin1 and their mutants were
subcloned into the pMX-puro vector 2. Transfection of 60% confluent PhoA cells was
performed using Fugene (Roche) and the virus harvested after 48 hours post-transfection.
MDA-MB-231 cell line was infected with the retrovirus tagged with green fluorescent
protein (GFP) and Rab5, Rin1 and control cell lines were generated and selected after 72
hours.
3.3.4. Rab5-GTP activation pull down assay
MDA-MB-231 cell lines were lysed using a buffer containing 20 mM HEPES (pH
7.5), 100 mM NaCl, 1 mM DTT, 5 mM MgCl2, 5% (v/v) glycerol and 1% (v/v) Triton-X100 supplemented with 1 mM PMSF. Lysates (1.5ug) were then incubated with 1μl antiactive Rab5 monoclonal antibody (Neweast Biosciences, Mavern, PA) overnight at 4°C.
The following day, cells were incubated with a protein A/G agarose bead slurry for 1 hr.
After incubation, the beads were washed three times using the lysis buffer and
resuspended in loading sample buffer. The pull-downs were subjected to SDS-PAGE and
analyzed by immunoblotting using an anti-Rab5 antibody.
3.3.5. Cell Proliferation Assay
The viability of cells was determined by the MTT assay. MDA-MB-231 cell lines
expressing Rab5 WT, the inactive form S34N, active form Q79L, Rin1, Rin2, Rin3, Rin1
mutant (R94A) or null vector were seeded in 96-well plates at a density of
25 × 103cells/well and incubated overnight. Cells were then serum starved for 24 hours
followed by treatment with serum and phenol red free DMEM with or without charcoal
stripped 5% FCS for 48 h. The MTT solution (5 mg/ml) was added to the plates and the
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cells incubated at 37 °C for 4 h. The formazan, derived from MTT by living cells, was
dissolved in 10% SDS (150 ml per well), and the absorbance was measured at 595 nm on
a plate reader. All MTT experiments were performed in triplicate and repeated at least 3
times.
3.3.6. Cell Migration/ Invasion assay
The ability of MDA-MB-231 cells passing through Matrigel coated or uncoated filters
was measured by the Boyden chamber invasion assay using Transwell inserts (8 μm
pores, Trevigen, MD). Cells suspended in serum-free and phenol free DMEM and
applied to the upper chamber. Serum and phenol free media with or without FCS as the
chemotractant added to the lower chamber and the plate incubated at 37oC for 24hrs.
Non-migrated cells in the upper well were removed and the membranes were fixed and
stained using 0.01% crystal violet. The membranes were either photographed or counted
under a light microscope (×100) or the dye extracted and the absorbance reading obtained
using a spectrophotometer.
For the Matrigel invasion assay, transwell inserts coated with 0.5 mg/ml Matrigel (BD
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol
free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and
phenol free media with or without charcoal stripped FCS was added to the lower chamber
and the plate incubated at 37oC for 24hrs. Susequently, the membranes were fixed,
stained, and photographed as above or absorbance readings acquired.
3.3.7. Wound-healing Assay
Cells were placed in inserts with a gap 500nm (+ 50nm) (Ibidi, Verona, WI) and
incubated at 37oC. After serum starvation for 24hrs, the inserts were removed, the wells
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were washed with PBS and medium with or without 5% charcoal stripped FBS was
added. Cell migration was determined under the inverted microscope and pictures were
obtained at time = 0 and t= 16hrs.
3.3.8. Anchorage-Independent Growth Assay
Briefly, 1 × 103 cells of each cell line were suspended in 300ul of DMEM containing
10% calf serum and 0.35% SeaPlaque low-melting temperature-agarose. These cells were
plated over a 300ul layer of solidified DMEM containing 10% calf serum and 0.6%
agarose, and cells were allowed to settle to the interface between these layers at 37 °C.
After 20 min, the plates were allowed to harden at room temperature for 30 min before
returning to 37 °C. 100ul of vehicle control or IGF-1 was added to wells and the plate
incubated at 37 °C. The plates were fed every 2–3 days. After 12-14 days, colonies were
photographed under low magnification (x10).
3.3.9. Western Blot Analysis
MDA-MB-231 cells were lysed with RIPA buffer containing protease inhibitor. Equal
amounts of protein (50 ug) were separated by SDS–PAGE gel electrophoresis and then
were electrotransferred to nitrocellulose membrane. Subsequent to blocking the
membrane with a solution containing 5% BSA- TBST buffer (20 mM Tris–HCl, pH 7.4,
150 mM qNaCl and 0.1% Tween 20) for 1hr, the membrane e was washed with TBST
buffer and incubated with the primary antibodies. Membranes were then washed; probed
with specific secondary antibodies and the proteins were detected by enhanced
chemiluminescence.
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3.3.10. Statistical Analysis
All samples in this study were analyzed in duplicate and each experiment was repeated
three times. Values represent the mean ± SEM of three independent experiments. To
compare two groups, student’s t test was utilized. P < 0.05 was considered as statistically
significant.
3.4. Results
3.4.1. IGF-1 endocytosis is mediated by Rab5 protein expression in breast cancer cells
To study the effects of Rab5, GFP-Rab5 constructs were transduced into the MDAMB-231 tumor cell line with a retrovirus system. Stable cell lines over-expressing Rab5
were stimulated with a physiological concentration of IGF-1. Rab5 activation upon IGF1 stimulation was examined by precipitating the active or GTP-bound form of Rab5
antibody (see Materials and Methods). After 5 minutes of growth factor stimulation, the
data shows that IGF-1 stimulation elicits a significant increase (a little over 3-fold) of
active Rab5 (Figure 8), suggesting that IGF-1 signaling may be Rab5 dependent in MDAMB-231 cells.
3.4.2. IGF-1 stimulated Rab5 activation in breast cancer cell overexpressing Rab5
specific GEFs
MDA-MB-231 cells were transformed using the aforementioned retrovirus system and
selected for overexpression of RIN1, RIN2 and RIN3. As it was previously described,
Rab5 activation can be described as molecular switch where GTPases cycle from an
inactive to an active form. This switch is mediated by Rab5- specific GEFs and may also
regulate RTK membrane trafficking.
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To evaluate if cells expressing RIN1, RIN2 and RIN3 may be a requirement for Rab5
activation in IGF-1R trafficking, the pull-down assay was performed to verify active
Rab5 presence in cells overexpressing RIN1, RIN2 and RIN3 in response to IGF-1. Cells
were incubated with IGF-1 for 5mins and the amount of active Rab5 generated was
quantified using SDS-PAGE after precipitating with active Rab5 monoclonal antibody.
3.4.3. Rab5 promotes cell migration and invasion in breast cancer cells
Cell migration and invasion were measured with the aid of a transwell system. Briefly,
cells expressing the different Rab5 constructs were placed in the Boyden chamber in
absence or presence of matrigel and incubated overnight. In Figures 10a and 10c, there
was a marked increase in the migratory and invasive potential of cancer cells over
expressing Rab5. As expected, cells expressing the constitutively inactive form of Rab5,
Rab5:S34N, inhibited migration and invasion of the cancer cells compared to the control
cells. While IGF-1 seems to have a profound impact on the migratory potential in the
S34N cell line when compared to cell invasion, it was still less that both the Rab5WT and
Rab5:Q79L active mutant.
These data also reveal that even in the absence of IGF-1, it seems that Rab5 activity
encourages more migration and invasion in both WT and Q79L cell lines when compared
to the GFP control. The migration abilities of the MDA-MB-231 breast cancer cell lines
were also verified using the wound healing method after 18 hrs. Cells transduced with the
Rab5-GDP bound form had a little migration, as the gap closure was similar to the 0hr
timepoint and wider than GFP control. Both Rab5:WT and Rab5:Q79L cell lines
demonstrated extensive gap closing which suggest that Rab5 activation may be key in
modulating such activity.
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3.4.4. The Ras-interfering family (RIN) increases cell proliferation, migration and
invasion upon IGF-1 stimulation
Given the results above, it was speculated that expression of Rab5 GEFs may also
induce cell proliferation, migration and invasion in breast cancer cells in response to IGF1. In MDA-MB-231, IGF-1 has been purported to exert a strong proliferative effect 7 and
it was necessary to verify if RIN expression may modulate this response in the breast
cancer cells. Cells expressing RIN1, RIN2 and RIN3 were plated, incubated for 48hrs in
the absence or presence of IGF-1 and the proliferative activity measured using the MTT
assay as described in the Materials and Methods. Figure 11 depicts the promotion of cell
proliferative by the RIN family of GEFs in response to IGF-1. To further validate the
function of RIN1 in IGF-1 signaling in cancer progression, cell migration and invasion
assays using the Boyden chamber as described in the Materials and Methods bolstered
previous data that the invasive and migratory activity of cells were augmented in
response to RIN1, RIN2 and RIn3 expression.
Figures 12a and 12b portrayed a strong increase in cell invasion and migration in
RIN1 and RIN3 cell lines, even in the absence of IGF-1, suggesting that RIN activity be a
driving force regardless of growth factor presence. RIN2 engendered an increase in
migration in the presence of IGF-1, while invasion was not noticeable when compared to
the control cell line.
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3.4.5. Functional role RIN1 on the invasive and migratory potential in MDA-MB231
Cells
As described in Figures 13a and 13b, RIN1 appears to be a principal regulator in
cancer cell metastasis. In Aim one, two scenarios arose with regard to RIN1 role in
growth factor signaling:
1. Action on Rab5 leading to its active form;
2. Interaction with the cystolic tail of the IGF-1R ensuring the internalization of
receptors and subsequent activation of the intracellular signaling pathways.
To further elucidate RIN1 function in growth factor signaling, stable cell lines
expressing RIN1 and the RIN1 mutant, R94A were created and the proliferative,
migratory and invasive capacities were studied. Jozic et al. showed that RIN1 facilitated
the fusion of the insulin receptor to the early endosome and was Rab5 dependent15 via
RIN1 activity. This study further supports the idea that RIN1 interacts with the IGF-1R
via the –SH binding domain as the R94A mutant significantly diminished proliferation,
migration and invasion in breast cancer cells. Interestingly during invasion, RIN1 seems
to have a greater interaction in response to IGF-1R as the absorbance was greater in
response to IGF-1 supplementation.
3.5. Discussion
Rab5 is an important factor in the regulation of intracellular vesicle transport and
recently garnered interest in its role in the pathogenesis of certain diseases, specifically
cancer. Earlier, it was shown that Rab5 may be an important protein in the onset of breast
cancer metastasis as non -aggressive tumorigenic breast cancer cells acquired a highly
89

invasive and migratory phenotype when Rab5 was overexpressed. Furthermore, IGF-1, a
potent mitogen seems to facilitate such changes as growth factors are integral in tumor
progression 4,9.
Studies have shown that Rab5 is expressed differentially in different cancer
subtypes38,40. Expression of Rab5 in non-invasive and invasive breast cancer cell lines
varies; where Rab5 distribution throughout the cells in different breast tumor grades were
disparately localized36.
As previously reported, an inherent relationship exists between RTK activation and
internalization

2,3,25

and has been attributed to Rab5 activation.

Figures 11 and 12

showed that IGF-1 activated the IGF-1R resulting in sequestration of active Rab5 to early
endosome and consequently the possible stimulation of the PI3K and MAPK pathways
which are necessary in initiating cell migration and invasion. While this study is the first
to show IGF-1 influence on the endocytic pathway on the migratory and invasive
capacity of MDA-MB-231 cells, Yang et al provided possible answers that most if not all
growth factors and their RTKs will have analogous behavior36.
In MCF7 cells, EGF did not promote cell migration despite the associated increase of
Rab5A expression. However, in MDA-MB-231 cells, the growth factor augmented the
migratory potential in relation to Rab5 expression and may be due to the RTK levels in
these cells. IGF-1R is found in all breast cancer cell lines regardless of estrogen receptor
status7 and is predominant in both estrogen responsive MCF7 and estrogen unresponsive
MDA-MB-231 cells. Although it is known that IGF-1 can stimulate the ER in the
absence of estrogen, this study supplements data from the first aim that the IGF-1R
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activation is necessary for migration and invasion of breast cancer cells and more than
likely does not involve crosstalk between the ER.
In this study, the role of Rab5 in facilitating IGF-1 induced breast cancer metastasis is
further clarified as overexpression of the Rab5WT and the active mutant form of Rab5
increased migration and proliferation. Conversely when inactive form of Rab5:S34N
mutant, was expressed, proliferation and migration was stemmed. Taken together, it can
deduced that the function of Rab5 is tightly linked to IGF-1 and IGF-1R signaling in
breast cancer metastasis.
During migration and invasion of cancer cells, reorganization and reconstruction of
the actin filament and microtubules are part of the morphological changes that these cells
undergo26,37. Cancer cells employ four key steps that facilitate this process: lamellipodia
formation and extension at the forefront, translocation of integrins to the leading edge,
contractile movement of the cell body and detachment of adhesion molecules at the rear
edge24. Actin remodeling and cell migration is dependent on Rho GTPase and Rac
activity of which these proteins are trafficked by Rab13 and Rab5 respectively and affect
the internalization of integrins during cell migration32,35,39.
Rab5 depletion in HeLa and SiHa cells affected integrin trafficking, compromised
filopodia and lamellipodia protrusion formation and reduced the cells’ capacity to
migrate and invade17, whereas in ovarian cancer, Rab5a overexpression elevated the
proliferative activity of ovarian cancer cells40. Migration of cells in hepatocellular
carcinoma was dependent on VEGF/PDGF (platelet derived growth factor) and EGFR
mediated tyrosine kinase endocytosis via Rab5 10, hepatitis B induced Rab5 expression28.
Consequently, the data and studies involving growth factor/ RTK trafficking and Rab5
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function collectively establish Rab5 as a regulator in IGF-1 mediated metastasis in breast
cancer cells.
Though Rab5 activation may be a requirement in cancer cell proliferation, migration,
invasion and survival, other factors may influence Rab5 activity and lead to the
internalization of the phosphorylated receptor. The RIN family of proteins are regulators
of Rab5 dependent early endocytosis via their GEF activity. They are homologous as they
share an SH2 domain, an RH region, a Vps9 domain and an RA domain. Though
controversial, RIN1 appear to exert its influence on Ras by inhibiting its action whilst
binding to H-Ras via the RA domain thereby competing with RAF133,34. In Aim1, it was
shown that both RIN1, RIN2 and RIN3 enabled MCF7 cells to garner a more hyperproliferative and invasive characteristic and this is reflected in the triple negative highly
invasive MDA-MB-231 cells. The conflicting role of RIN1 function can only be resolved
by viewing RIN1 activity in RTK trafficking in a context-specific manner. On one hand,
RIN1 may be a breast cancer tumor suppressor gene13,19 by suppression of cancer
tumorigenesis and inhibition of transforming growth factor β (TGFβ) signaling. The
latter however has contrary roles in tumorigenesis and metastasis as typically in early
non-metastatic tumor (epithelial to mesenchymal transition), TGFβ levels are too low to
facilitate such change, yet once cells are malignant, TGFβ promote cancer progression
and dissemination31. This may be the case for this study, as MDA-MB-231 are already
quite aggressive and over expression of RIN1 has a paradoxical effect and instead
augments proliferation and invasion of the cells in response to IGF-1. Previous studies
have indeed highlighted RIN1 expression as a major indicator of cancer metastasis and
progression8,27.
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IGF-1 has a significant effect on triple negative breast cancer cell lines by fostering
proliferation and reducing apoptosis and attenuation of such response and when the IGF1R expression was curbed7, cell proliferation and survival was abrogated. Modulation
IGF-1R trafficking affected the proliferative, migratory and invasive potential of breast
cancer cells. RIN1 beside possessing a Rab5 specific binding domain, also encodes a
SH2 binding site that may interact with the insulin receptor substrate (IRS) on the
phosphorylated tyrosine residues of the IGF-1R

21

. Here, mutation in the SH2 binding

domain of RIN1 implied that RIN1 is crucial in IGF-1 signaling as cells expressing the
RIN1 mutant, R94A, considerably moderated proliferation, migration and invasion of
MDA-MB-231. Therefore it can be tentatively concluded that RIN1 is first recruited to
the activated receptor, then engages Rab5 via its Vsp9 binding domain, with Rab5
subsequent activation. Comparatively, SH2 dependent interaction has been illustrated for
RIN1 and other RTKs, specifically EGFR resulting in the recruitment and internalization
of activated RTKs in endosomes14,30.
Overall, the data presented shows that both Rab5 and RIN1 point to a novel
relationship between IGF-1R trafficking and endocytosis in the regulation of migration
and invasion of breast cancer cells. It remains to further elucidate if IGF-1R
internalization may also be clathrin or caveolin dependent and the effect of IGF-1R
trafficking on downstream signaling in IGF-1 driven breast cancer cell invasion and
migration.
3.6. Figures
Figure 8
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Figure 10. IGF-1 mediates cell invasion and migration in MDA-MB-231 cells via Rab5
activation. In Figures 10a and b, cells were plated in a Boyden chamber without or

without basement extract membrane. Both kinase and caveolin inhibitors were added to
cells for 1hr. Treatment groups were IGF-1 or vehicle control and cells were incubated ta
37oC for 16hrs. Crystal violet staining was performed and the dye extracted and the OD
measuring using a plate reader at 595nm. Cell migration and invasion absorbance reading
were expressed as average ± SEM for three independent experiments. For MDA-MB-231
cell migration (Fig. 10b), an IBIDI culture insert (IBIDI GmbH) was placed into wells of
a 24 well plate and slightly pressed on the top to ensure tight adhesion. An equal number
of cells were placed in each of the insert and the cells incubated for 16hrs. Gap closure
was observed at a magnification of 10X and images recorded. Crystal violet staining was
done for better imaging of the migration of the cells. Each cell line was done in triplicate
with data represent the mean absorbance ± SEM of the three independent wells. (*)
represents statistically significant difference from control group (P<0.05); (**) is
(P<0.01).
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Figure 11. The Ras-interfering family (Rin) increases cell proliferation upon IGF-1
stimulation. Cells expressing either GFP, RIN1, RIN2 and RIN3 were incubated in the
absence or in the presence of IGF-1 in triplicate. Cell proliferation was assessed after
48hr incubation with vehicle or IGF-1 of cell culture, using the MTT proliferation assay
(Sigma). Briefly after the incubation period, cells were added with 100 μL of 5 mg/mL
thiazolyl blue tetrazolium bromide (Sigma, St. Louis, MO) solution/well and were
incubated further for 4hrs in a humidified atmosphere (37°C in 5% CO2). The
absorbance was measured at 560nm in a microplate reader. Cell proliferation was
expressed as the mean absorbance compared to vehicle control ± SEM for three
independent experiments. (*) represents statistically significant difference from control
group (P<0.05); (**) is (P<0.01); (***) is (P<0.001)
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Figure 12. RIN1 and its family facilitate an increase in invasion and migration upon
IGF-1 stimulation in cancer cells. Cells expressing either GFP, RIN1, RIN2 and RIN3
were incubated in the presence or absence basement extract membrane in a Boyden
chamber in triplicate. Treatment groups were IGF-1 or vehicle control and cells were
incubated ta 37oC for 16hrs. Crystal violet staining was performed and the dye extracted
and the OD measuring using a plate reader at 595nm. Cell invasion and migration was
expressed as the mean absorbance compared to vehicle control ± SEM for three
independent experiments. (*) represents statistically significant difference from control
group (P<0.05); (**) is (P<0.01); (***) is (P<0.001)
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Figure 13a. IGF-1 enhances cell proliferation through GEF overexpression. Cells
expressing either GFP , RIN1, and the RIN1 mutant R94A were incubated in the absence
or in the presence of IGF-1 in triplicate. Cell proliferation was assessed after 48hr
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incubation with vehicle or IGF-1 of cell culture, using the MTT proliferation assay
(Sigma, St. Louis, MO). Briefly after the incubation period, cells were added with 100 μL
of 5 mg/mL thiazolyl blue tetrazolium bromide (Sigma, St. Louis, MO) solution/well and
were incubated further for 4 h in a humidified atmosphere (37°C in 5% CO2). The
absorbance was measured at 595 nm in a microplate reader. Cell proliferation was
expressed as the mean absorbance compared to vehicle control ± SEM for three
independent experiments. (*) denote p value < 0.05 for vehicle control. Effect of Rin1
on the invasive and migratory potential in MDA-MB231 cells. In Figure b, MDAMB231 cells were infected with Rin1, Rin1 mutant R94A and the null vector GFP. Cells
were placed in a Boyden chamber with or without basement extract membrane (Figures
b. and c. respectively) Treatment groups were IGF-1 or vehicle control and cells were
incubated ta 37oC for 16hrs. Crystal violet staining was performed and the dye extracted
and the OD measuring using a plate reader at 595nm. The average OD ± SEM of the (b.)
cell invasion and (c.) cell migration readings were obtained for three independent
experiments. (*) denotes (P< 0.05), (**) is (P<0.01), (***) is (P<0.001).
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CHAPTER 4.
Caveolin dependent trafficking of IGF-1R is a key step in Cell Migration and
Invasion of Breast Cancer Cells
Within this chapter, the functional roles of Rab5 and RIN1 in IGF-1R trafficking were
further characterized. The effect on the gene expression was of a key protein in cell
invasion, MMPs was also investigated.
4.1. Abstract
IGF-1signaling has been extensively studied in several developmental contexts and
most recently within cancer pathogenesis. IGF-1 is known to increase cell proliferation
and survival and may also be implicated in cell migration and cell invasion. However,
there is a dearth of information regarding IGF-1R trafficking upon IGF-1 stimulation in
breast cancer progression. It has been described that Rab5 and its GEF, RIN1, play key
roles in RTK trafficking and influence the invasive and migratory potential of cells.
In this study, two non-invasive ER positive and highly invasive triple negative breast
cancer cell lines were transfected with Rab5 and RIN1 constructs and the mechanisms
surrounding IGF-1R endocytosis was investigated. Blocking of the IGF-1R revealed that
IGF-1 signaling was contingent on receptor activation and recruited RIN1 and early
endosome formation via a sẅcaveolae dependent mechanism. Furthermore, Rab5 and
RIN1 overexpression increased MMP9 expression establishing a novel link among IGF1R activation and signaling and MMP activation in migration and invasion of breast
cancer cells.
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4.2. Introduction
Like most if not all cancers, breast cancers commandeer highly regulated signaling
pathways and alter these signaling pathways resulting in autonomous growth signal
entities17,42. They upset the delicate balance by promoting the binding of multiple growth
factors to cell surface receptors, synthesize growth signals that can either bind to their
own receptor, forming an autocrine loop or influence the secretion of more growth factors
by normal cells into the stroma6,13, which then binds again to the receptors on the cancer
cells, creating a paracrine feedback loop.
In mammary epithelial cells, malignancy has been attributed to an increase in cell
proliferation, survival and metastasis, specifically cell migration and invasion. IGF-1 has
been strongly implicated in breast cancer progression as it facilitates cell proliferation and
survival in breast cancer cells18. In fact, circulating IGF-1 levels have a strong positive
correlation with worsening breast cancer prognosis, especially among menopausal
women18, thereby indicating that breast cancer is not always hormonally dependent as
previously believed.
While growth factors may induce transformations in signaling pathways in cancer
pathogenesis, Rab proteins have also been specifically linked to the deregulation of
several signaling pathways in several cancers12. These small monomeric enzymes are
implicated in the promotion of abnormal proliferation, migration and invasion of
epithelial cells in tumor progression due to activation of membrane bound growth factor
receptors. Rab5 is one such GTPase that is gaining notoriety in tumor progression and
metastasis27,40. As it was previously shown in the aforementioned Aims, Rab5 activity
play a key role in cell migration and invasion in both estrogen positive and negative

109

breast cancer cell lines. Furthermore, it is believed that disruption of the endocytic
pathway confers growth factor autonomy to cancer cells by passing key endocytic
processes such as lysosomal degradation and instead promote the recycling of growth
factors as well as integrins11,15,28.
IGF-1 binds to a variety of insulin-like growth factor receptors (IGFRs) including the
insulin receptor (IR). These receptor tyrosine kinases (RTKs), when activated, transduce
signals through PI3K and MAPK-dependent mechanisms which are responsible for the
diverse target actions of these growth factors. These include increases in cell division,
cell size, protein synthesis, cell migration, and inhibition of apoptosis21. IGF-1 can also
potentiate VEGF expression of tumor cells and inhibit apoptosis by binding to caspase 9,
which is unable to cleave caspase 3 and halting the caspase cascade to apoptosis36. The
pro-survival effect of IGF-1 also allows detached pre-metastatic cells to escape anoikis 20
, facilitate the secretion of more growth factors by cancer cells and induce ECM
degradation by enabling the matrix metalloproteinases (MMPs) expression and
secretion39. IGF-1 also mediate cell migration of cancer cells by reorganizing integrin
receptors, and modulating the E-cadherin/ β-catenin complex which in turn, augment
MMPs expression and the migratory potential of the cells41.
The aforementioned studies (Aims 1 and 2) illustrated that IGF-1 signaling is
mediated by Rab5 and RIN1 activities. Recently, it was acknowledged that IGF-1R is
internalized via clathrin and caveolin dependent mechanisms in Ewing sarcoma30 cells
and is localized in the nucleus in prostate, renal and breast tumor cells after translocation
from the cell surface via clathrin mediated endocytosis1. Yet, during IGF-1 driven cell
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invasion and migration of breast cancer cells, it is remains unclear if IGF-1R trafficking
is caveolin dependent or independent. In this study, IGF-1R trafficking utilized primarily
caveolin dependent, and inhibition of IGF-1R activation and/ or internalization can alter
cancer cell progression. Hence, there is a novel link between RIN1, Rab5, MMP9
expression and IGF-1R signaling in tumorigenesis and metastasis in both non-invasive
and invasive cancer cells.
4.3. Materials and Methods
4.3.1. Media and Antibodies
Trypsin and DMEM were purchased from Fisher Scientific. Basement extract
membrane was obtained from Trevigen (Gaithersburg, CA). The following antibodies
were used for Western blotting: Rab5, MMP-9, anti-ERK, p38, Akt, phospho-ERK,
phospho-cJun, phospho-p38, phospho-Akt, GAPDH , (Cell Signaling Technology,
Danvers,MA).

Anti-mouse, and anti-rabbit IgG peroxidase-conjugated secondary

antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove,
PA). Kinase inhibitors were obtained from Sigma (St. Louis, MO).
4.3.2. Cell Culture
The human breast cancer cell line, MDA-MB-231, was obtained from the American
Type Culture Collection (ATCC; Manassas, VA, USA). Cells were maintained in DMEM
medium supplemented with 10% FCS, 2mM glutamine, and antibiotics (100 U/mL
penicillin and 100μg/mL streptomycin) at 37oC in a humidified atmosphere of 5% CO2.
4.3.3. Construction of recombinant pMX-puro retroviruses and cell lines
As previously described, the cDNAs of Rab5 and Rin1 and their mutants were
subcloned into the pMX-puro vector 5.Transfection of 60% confluent PhoA cells was
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performed using Fugene (Roche) and the virus harvested after 48hrs post-transfection.
MCF7 and MDA-MB-231 cell lines were infected with the retrovirus tagged with green
fluorescent protein (GFP) and Rab5, Rin1 and control cell lines were generated and
selected after 72hrs.
4.3.4. Cell Proliferation Assay
The viability of cells was determined by the MTT assay. MCF7 and MDA-MB-231
cell lines expressing Rab5 WT, Rin1, Rin1 mutant (R94A) or null vector were seeded in
96-well plates at a density of 25 × 103cells/well and incubated overnight. Cells were then
serum starved for 24hrs followed by treatment with serum and phenol red free DMEM
with or without charcoal stripped 5% FCS for 48hrs. The MTT solution (5 mg/ml) was
added to the plates and the cells incubated at 37 °C for 4hrs. The formazan, derived from
MTT by living cells, was dissolved in 10% SDS (150μl per well), and the absorbance
was measured at 595nm on a plate reader. All MTT experiments were performed in
triplicate and repeated at least 3 times.
4.3.5. Cell Migration and Invasion Assays
The ability of MCF7 and MDA-MB-231 cells passing through Matrigel coated or
uncoated filters was measured by the Boyden chamber invasion assay using Transwell
inserts (8μm pores, Trevigen, MD). Cells were suspended in serum-free and phenol free
DMEM and applied to the upper chamber. Serum and phenol free media with or without
FCS as the chemotractant was added to the lower chamber and the plate incubated at
37oC for 24hrs. Non-migrated cells in the upper well were removed and the membranes
were fixed and stained using 0.01% crystal violet. The membranes were either
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photographed or counted under a light microscope (×100) or the dye extracted and the
absorbance reading obtained using a spectrophotometer.
For the Matrigel invasion assay, transwell inserts coated with 0.5μg/ml Matrigel (BD
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol
free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and
phenol free media with or without charcoal stripped FCS was added to the lower chamber
and the plate incubated at 37oC for 24hrs. Subsequently, the membranes were fixed,
stained, and photographed as above or absorbance readings acquired.
4.3.6. Wound-healing Assay
Cells were placed in inserts with a gap 500nm (+ 50nm) (Ibidi, Verona, WI) and
incubated at 37oC. After serum starvation for 24hrs, the inserts were removed, the wells
were washed with PBS and medium with or without 5% charcoal stripped FBS was
added. Cell migration was determined under the inverted microscope and pictures were
obtained at time = 0 and 16hrs.
4.3.7. Anchorage-Independent Growth Assay
Briefly, 1 × 103 cells of each cell line were suspended in 300ul of Dulbecco’s
Modified Eagle’s medium containing 10% calf serum and 0.35% SeaPlaque low-melting
temperature-agarose. These cells were plated over a 300ul layer of solidified Dulbecco’s
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were
allowed to settle to the interface between these layers at 37 °C. After 20 min, the plates
were allowed to harden at room temperature for 30 min before returning to 37 °C. 100ul
of vehicle control or IGF-1 was added to wells and the plate incubated at 37 °C. The
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plates were fed every 2–3 days. After 12-14 days, colonies were photographed under low
magnification (x10).

4.3.8. RNA Isolation
After treatments of 15minutes, 1hr or 24 hrs, total RNA from MCF-7 cells was
extracted using an RNAeasy mini kit (Qiagen) according to the manufacturer's
instructions. The integrity and purity of the total RNA were checked using a
Spectrophotometer (GE Healthcare).
4.3.9. Synthesis of Complementary DNA and Quantitative (real-time) PCR
Complementary DNA (cDNA) was created using qScript™ cDNA synthesis kit
(Quanta BioSciences). Q-PCR was performed using the CFX96™ Real-Time PCR
Detection System (Bio-Rad) in a two-step procedure using SSo Fast (Biorad).
Amplification of 18s was performed to standardize the amount of sample cDNA. Primer
were 18s, Rab5a, Rab5b, MMP9 (Life Technologies). All reactions were performed in a
96 well plate with the following cycling conditions: 40 cycles of 95°C for 15s, and 60°C
for 30 s, 72°C 1 min. To report fold changes, ΔΔCt values were obtained and fold change
is derived as 2−ΔΔCt with the value of each control sample was set at 1 and used to
calculate the fold-change of target genes.
4.3.10. Statistical Analysis
All samples in this study were analyzed in duplicate and each experiment was repeated
three times. Values represent the mean ± SEM of three independent experiments. To
compare two groups, student’s t test was utilized. P < 0.05 was considered as statistically
significant.
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4.4. Results
Rab5 and RIN1 regulated IGF-1 signaling induced morphological changes in MCF7
cells consistent with Epithelial Mesenchymal Transition
Previous studies have shown that there is an intrinsic relationship between IGF-1
signaling and breast cancer34,41. Here, the morphological changes that occurred in MCF7
breast cancer cells overexpressing Rab5 and RIN1, when treated with IGF-1, suggest this
may be consistent with EMT.
In Figure 14a, cells were treated with IGF-1, and subsequently stained with phalloidin
to visualize the actin filaments. In IGF-1 treated cells, more actin accumulated to the edge
of the cells (Figure 14a. arrows), particularly in Rab5 and RIN1 overexpressing cell lines.
Further examination also illustrated that some cells underwent a shift in epithelial
morphology as they were more elongated and fibroblast-like, and similar in
morphological characteristics like the invasive breast cancer cell line, MDA-MB-23126.
4.4.2 Inhibition of IGF-1R trafficking modulated cell migration and invasion of MCF7
cells.
As it was ascertained in Aims 1 and 2, both Rab5 and RIN1 expression is required for
IGF-1 signaling which drive cell migration and invasion. It is known that IGF-1 signaling
is dependent on IGF-1R activation9,24. IGF signaling is initiated by the binding of the
IGF-1 ligand to the IGF-1R and the subsequent auto-phosphorylation of tyrosine residues
of specific cytosolic kinase domains14,29,35 and the association specific adaptor molecules
such as IRS, Shc25 and RIN123. To determine if IGF-1 signaling was mediated through
the IGF-1R in breast cancer cells, an IGFR inhibitor, AG102432 was administered to the
cells for 1hr prior to cell invasion and migration assays.
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In Figures 14b and 14d, AG1024 abrogated migratory and invasive capacity of MCF7
cells expressing either Rab5 or RIN1, thereby suggesting that the IGF-1R is involved
IGF-1 signaling in breast cancer progression. Considering that Rab5 has been implicated
in the endocytosis of RTKs, it was imperative that the actual mechanism of IGF-1R
internalization was clarified. IGF-1R endocytosis has been said to be both clathrin and
caveolin dependent30. The latter, however has a stronger affinity in IGF-1 signaling7,37
and it was worth investigating if IGF-1 signaling in breast cancer was dependent on lipid
raft formation. MCF7 cells were pre-treated for 1hr with the caveolin inhibitor i.e.
Filipin, and the effect on migration and invasion observed using the Boyden chamber.
Like the IGF-1R inhibitor, Filipin suppresses cell migration and invasion of MCF7 cells,
particularly in RIN1 over-expressing cells. Cells overexpressing Rab5, while showing a
decrease compared to the control, possessed a higher migratory and invasive potential
like RIN1 expressing MCF7 cells, implying that there may be a possible link between
RIN1 activity and caveolin invagination of the IGF-1R.
4.4.3 Colony formation requires caveolin dependent IGF-1R trafficking
During cancer progression there are two main phases of tumor formation, the onset of
hyper-proliferative growth and primary colony formation during the pre-metastatic phase,
and the secondary colony formation, post metastasis17. Based on previous results, it was
illustrated that IGF-1 promotes aggressive tumor growth from single tumor cells in
agarose suspension. Most importantly, it was dependent on Rab5 and RIN1 activity,
suggesting that the IGF-1R may play an integral role in colony formation. In the presence
of the AG1024 or Filipin inhibitors (Figure 14g), colony formation was significantly
curbed, providing additional evidence that IGF-1R is involved in breast cancer
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progression. Furthermore, this IGF-1R involvement requires trafficking to the early
endosome via a caveolin dependent mechanism possibly through the invagination to the
caveosome and docking on the early endosome.
4.4.4 AG1024 and Filipin modulates cell migration and invasion in MDA-MB-231 cells
Since cell migration and invasion was negated in MCF7 cells in the presence of
inhibitors, it was interesting to see if in a highly invasive breast cancer cell line, the
ability for cells to migrate and invade would also be affected. MDA-MB-231 cells were
also transduced with GFP, Rab5 and RIN1 and pretreated with AG1024 or Filipin for
1hr. Migration and invasion was assayed using the Boyden chamber and after 18hrs, the
absorbance of migrated and invaded cells was quantified.
As expected, there was a reduction in cell migration and invasion in the presence of
the kinase or caveolin inhibitor (Figures 15 a , c, d and e ). Unlike MCF7, Rab5WTexpressing MDA-MB-231 cells migrated and invaded less than RIN1 cells.
Cell migration and invasion was largely unaffected in RIN1:R94A cells compared to
controls, implying that RIN1 is recruited upon IGF-1R stimulation prior to caveolindependent internalization of the receptor. Figure 15b, illustrated that inhibition of the
IGF-1R significantly affected migration in both Rab5WT and RIN1 breast cancer cell
lines supplementing the data obtained that IGF-1R must be involved in IGF-1 signaling
in breast cancer progression.
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4.4.5 RIN1 mediates IGF-1 induced expression consistent with IGF-1R trafficking in
breast cancer cells
To determine if Rab5 expression is substantial upon IGF-1 stimulation in RIN1
expressing cancer cells, real-time PCR was performed with primers for Rab5a and Rab5b
in both MCF7 and MDA-MB-231.
Figure 16a shows the role of Rab5a in cancer progression and the importance of the
receptor in IGF-1 signaling during disease progression. In the presence of the kinase
inhibitor, there was considerable down-regulation of Rab5a expression when compared
to IGF-1 control (where the fold change >2 is considered significant) in cancer cells
overexpressing RIN1. Addition of Filipin also induced marked suppression of Rab5a in
the presence of IGF-1. This clearly denotes that Rab5a function in IGF-1 signaling in
breast cancer cells may be dependent upon caveolin mediate internalization of the IGF1R. In MDA-MB-231 cells, the outcome was similar to MCF7 with AG1024 repressing
Rab5a gene activity (Figure 16d). To verify if other Rab5 isoforms may be involved in
IGF-1R trafficking in breast cancer cells, Rab5b expression was observed. Surprisingly,
Rab5b expression was comparable to Rab5a, where Rab5b was up-regulated significantly
in the presence of IGF-1 and inhibited when AG1024 was introduced (Figures 16f). A
key finding (Figures 16c and e) demonstrated that Rab5 gene expression was affected in
cells expressing RIN1:R94A mutant, indicating that the ability of RIN1 to bind to the
activated receptor is necessary for Rab5 function in early endocytosis of the receptor.
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4.4.6 Endocytosis of the IGF-1R increased metalloproteinase expression in breast
cancer cells
During cancer cell invasion, proteases are stimulated and secreted by growth factors
including IGF-117,41. Given earlier data that illustrated acquisition of fibroblast like
phenotype in MCF7 cells upon IGF-1 stimulation (Figure 14a), the next step was to
ascertain if Rab5 and RIN1 trafficking of the IGF-1R facilitates protease expression.
Using real time PCR with primers for MMP9 in both MCF7 and MDA-MB-231 cell
lines, MMP9 gene expression was significantly enhanced in cell s overexpressing Rab5
and RIN1. In MCF7 cell (Figure 17b), Rab5 expression elicited a 10-fold increase in
MMP9 gene expression. RIN1 elicited lower but still significant levels of MMP9 mRNA,
about 2.5 fold change in both MCF7 and MDA-MB-231 (Figure 17b and 17c
respectively). Addition of AG1024 and Filipin to MCF7 cells (Figure 17c) reduced
MMP9 expression with the fold changes at 1 or less, supplementing the cell invasion data
that the inhibitors repress the invasive capacity of MCF7 in the presence of IGF-1. While
one of the traits of MDA-MB-231 is a highly invasive phenotype, it is shown that MDAMB-231 in response to IGF-1 can up-regulate MMP9 gene expression, via RIN1 activity
(Figure 17d and e). Moreover, RIN1:R94A significantly suppressed MMP9 expression
corroborating RIN1 and Rab5 roles in cell invasion.
4.5. Discussion
Proliferation, migration and invasion are regulated by a wide array of growth factors
and cytokines in cancer metastasis8. Growth factor signaling are reliant on receptor
phosphorylation and the utilization of specific inhibitors for RTKs are important in
elucidating the role growth factors and their receptors in membrane trafficking and
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signaling

10

in cancer cell migration and invasion. In fact, RTK activation is pervasive

during the endocytic process, from internalization to lysosomal and/or recycling
processes.
Here (Figures 14b and 14d), it was demonstrated that the IGF-1 inhibitor, AG1024,
suppressed the invasive and migratory activity of MCF7 breast cancer cells indicating
that IGF-1 signaling was dependent on the IGF-1R. Rab5a expression was significantly
diminished when the IGF-1R was blocked (Figure 16a), implying that the receptor must
be activated for Rab5 mediated early endocytosis to occur. Confirmation that
internalization of IGF-1R can be clathrin independent30,37 was validated by the addition
of Filipin, indicating that IGF-1R endocytosis is caveolin-dependent and entailed Rab5
activation and early endocytic function (Figure 16b). Down-regulation of Rab5a through
IGF-1R inhibition led to decreased cell invasion and migration, supporting previous
reports from this study that growth factor driven cell migration and invasion was Rab5
dependent in breast cancer cells.
In MDA-MB-231 cells (Figures 15a and 15d), it appears that there was partial
blocking of the IGF-1R in cells overexpressing RIN1, suggesting that IGF-1 signaling
was also mediated by another mechanism independent of the IGF-1R. Within anchorage
independent conditions, it was ascertained that IGF-1 interacts with the Integrin receptor
(αvβ3) and facilitates IGF-1 signaling regardless of IGF-1R inhibition16. Integrins are
heavily involved in the cell migration process during cancer progression and Rab5 is
known to regulate αvβ3 endocytosis
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. Hence, it can be assumed that during cell

migration of breast cancer cells, IGF-1 can also stimulate the αvβ3 receptor, leading to
the RIN1 interaction of Rab5 and sequestering of the active Rab5 complex to the cell
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membrane and subsequent endocytosis of the αvβ3 receptor. On the other hand, RIN1
binds to non-receptor ABL tyrosine kinases, where the latter arbitrates RTK
phosphorylation and endocytosis, and directs actin remodeling in cell migration22,38.
RIN1 directed endocytosis of the RTK and the ultimate fate of the receptor involves a
delicate balance between RIN1:Rab5 and RIN1:ABL interaction3. Specifically, ABL
confers a protective influence on RTK activity, increase active Rab5 levels stabilized the
receptor and shifted the mechanism to increased receptor internalization and recycling,
and directed cell motility4.
In Figure 15a, despite the presence of Filipin, MDA-MB-231 cells overexpressing
RIN1 may utilize ABL signaling via IGF-1R phosphorylation, bypassing caveolae
receptor internalization. Taken together, it can be concluded during IGF-1-directed cell
migration and invasion in breast cancer, IGF-1 signaling is both dependent and
independent on IGF-1R.
IGF-1 has engendered morphological changes in breast cancer cells via TGF
activation41 where atypical epithelial cells acquired an EMT configuration. This study
revealed that in MCF7 cells overexpressing RIN1 and Rab5, IGF-1 stimulated breast
cancer cells had modified morphological features as they were more elongated and
fibroblast-like, typical of cells undergoing EMT17. During EMT, protease activity is
integral, allowing cells to migrate and invade to distal tumor sites. Based on this, it was
imperative to determine if MMP expression was correlated with IGF-1R trafficking in
breast cancer cells.
MMPs are intergral family of endopeptidases involved in the metastatic potential of
cancer. Walsh et al highlighted that IGF-1 significantly increased MMP expression and
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subsequently the proteolytic

and invasive response of MCF7 cells41 Few studies

currently exist that illustrate the functional role of enodcytosis in the regulation and
trafficking of MMPs. In breast cancer cell lines expressing the estrogen receptor, Rab27b
has been implicated in the regulation of MMP-2 activation through heat shock protein
(Hsp) 90a secretion and stimulate invasion of breast cancer cells19,31. Growth factor
stimulated breast cancer cells overexpressing Rab5a affected Rab4 and Rabenosyn-5dependent endo/exocytic cycles in the ferrying of the matrix protease, MMP-1 and β3
integrin15. This trafficking cycle produced a chemotactic-dependent invasive and
proteolytic mesenchymal response in breast carcinoma cells in vitro and in vivo15.
Here, it is shown that an inherent relationship may exist between endocytosis and
MMP9 activity in the presence of IGF-1. In both ER positive and ER negative cell lines,
MMP9 expression increased in response to IGF-1 stimulation (Figures 17a-e). Inhibition
of the IGF-1R suppressed MMP9 levels showing persuasive the role of IGF-1 signaling
in breast cancer cell invasion (Figures 17c and e). In the archetypal non-invasive MCF7
cells line, Rab5 over-expression garnered the most positive change in MMP9 gene
expression (Figure 17b). This hints, not only of the potency of IGF-1 in accelerating the
alteration to an aggressive breast cancer phenotype and behavior, but also the importance
of Rab5 in mediating protease secretion and action during IGF-1R trafficking in breast
cancer cell invasion.
As described above, IGF-1R internalization is caveolin dependent as Filipin hindered
MMP9 gene expression in response (Figure 17c). Conversely, given the highly invasive
nature of MDA-MB-231 cells, it was expected that MMP9 expression would be more
dominant compared to MCF72. Yet, MMP9 gene expression, while significant, was
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almost the same (about 2.5 fold) compared to protease expression in MCF7 cells. Perhaps
this can be ascribed to the fact that as MDA-MB-231 is already highly invasive, the
change in MMP9 expression in response to growth factor would not be as drastic
compared to the MCF7 cells undergoing IGF-1-mediated transformation to an aggressive
status. As expected, the RIN1:R94A cell line affected MMP9 expression. Therefore the
inability for RIN1 to bind to the IGF-1R down-regulated MMP9 expression (Figures
17d).
In summation, this study illustrates a novel model in IGF-1 signaling in breast cancer
progression. IGF-1 signaling relies heavily on the IGF-1R activation and caveolaedependent trafficking through Rab5 and RIN1 activity. Additionally, this study show for
the first time that there may be a link between caveolin dependent endocytosis and RIN1
activation in IGF-1 signaling. RIN1 overexpression increases endogenous caveolin-1 in
early endosomes, and upon internalization, translocation and tethering of active
caveosomes to the early endosomes is Rab5 dependent33. The interplay between IGF-1R
trafficking and MMP9 activation through RIN1 and Rab5 GTPases function elucidates
one of the mechanisms of invading breast cancer cell. With the establishment of Rab5
and it GEF, RIN1 as crucial regulators in IGF-1 signaling in cancer cell migration and
invasion, characterization of the RIN1- caveolin interaction as well as downstream
signaling pathway need to be further studied.
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Figure 14a Rab5 and RIN1 influenced morphological changes in MCF7 cells when
treated with IGF-1. Figure 14a illustrated the mobilization of actin fibers in MCF7 cells
to the cell surface in response to IGF-1 with a strong response in Rab5 and RIN1 cell
lines. Cells were seeded on coverslips, incubated for 18hrs in the absence or presence of
IGF-1. After fixing and staining with actin phalloidin, the prepared slides were observed
under a confocal microscope. Cytoskeleton was stained with phalloidin (red) and the
nucleus with DAPI (blue) with more actin (red) was seen accumulating to the cell surface
in IGF-1 treated cells. In MCF7 cell lines, IGF-1 signaling requires IGF-1R activation
and dependent on caveolin mediated internalization. Figures 14b, c ,e and f, migration
and invasion of the tumor cells were affected by both the kinase and caveolin inhibitors.
Cells were plated in a Boyden chamber without or without basement extract membrane.
Both kinase and caveolin inhibitors were added to cells for 1hr. Treatment groups were
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IGF-1 or vehicle control and cells were incubated ta 37oC for 16hrs. Crystal violet
staining was performed and the dye extracted and the OD measuring using a plate reader
at 595nm. Cell migration and invasion absorbance readings were expressed as average ±
SEM for three independent experiments. Using an IBIDI gap closure system, Figure 14d
is a representative picture depicting the effect of AG1024 on cell migration MCF7, where
blocking of IGF-1R signaling down-regulated IGF-1R trafficking in Rab5 and RIN1
overexpressing MCF7 cells. In Figure 14g, cells were pretreated for 1hr with the
inhibitors, followed by sparse seeding in agarose and cultured for 14 days with or with or
without IGF-1. At the end, pictures of colony formation from single cells were taken and
the average number of colonies were calculated for 3 random areas of each well. As
shown, both Rab5 and RIN1 cells had more colonies in response to IGF-1. Inhibition of
the IGF-1R and caveolin suppressed colony formation particularly in response to IGF-1.
(*) denotes (P<0.05), (**) is (P<0.01), (***) is (P<0.001)
Figure 15
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Filipin suppresses cell migration and invasion of MDA-MB-231 cells upon IGF-1
stimulation. (Figures 15a, c, d, e) Cells were plated in a Boyden chamber without or
without basement extract membrane. Both kinase and caveolin inhibitors were added to
cells for 1hr. Treatment groups were IGF-1 or vehicle control and cells were incubated ta
37oC for 16h. Crystal violet staining was performed and the dye extracted and the OD
measuring using a plate reader at 595nm. Cell migration and invasion absorbance reading
were expressed as average ± SEM for three independent experiments. (*) denotes
(P<0.05), (**) is (P<0.01), (***) is (P<0.001). In Figure 15b, an IBIDI culture insert
(IBIDI GmbH) was placed into wells of a 24 well plate and slightly pressed on the top to
ensure tight adhesion. An equal number of cells were placed in each of the insert and the
cells incubated for 16hrs. Gap closure was observed at a magnification of 10X and
images recorded. Crystal violet staining was done for better imaging of the migration of
the cells
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Figure 16. Real time PCR showed Rab5 expression and activation is dependent on
IGF-1R phosphorylation and internalization via caveolae-mediated mechanism.
Figure 16a shows Rab5a expression in wildtype MCF7 cells after IGF-1 stimulation.
MCF7and MDA-MB-231 cells overexpressing RIN1 were pre-treated with AG1024 or
FIlipin for 1hr and treated with IGF-1 or vehicle control. In Figure 16b, Rab5a levels was
11 fold compared with a sharp decrease in Rab5a expresson in the presence of the
inhibitors. Figures 16 c and d complements the MCF7 data, showing Rab5a expression
was also elevated upon IGF-1 stimulation and reduced in the presence of AG1024 and the
RIN:R94A mutant. Rab5a, had a 4-fold increase in gene expresson with similarly
inhibition of Rab5b gene levels in the presence of AG1024 in R94A cell lines.
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Figure 17. Real time PCR showed MMP9 expression and activation is dependent on
IGF-1R phosphorylation and internalization via caveolae-mediated mechanism.
MCF7 and MDA-MB-231 cells overexpressing Rab5a and RIN1 were pre-treated with
AG1024 or Filipin for 1hr and treated with IGF-1 or vehicle control. Figure 17a. depicts
MMP9 expression at an early and late time. In (b), MMP9 expression was notably
elevated 11 fold compared to the vehicle control in 7 cells while in (d), disruption of the
caveolae pathway also inhibited MMP9 expression while in RIN1:R94A mutant cells,
MMP9 expression was also decreased. Figures (c) and (d) shows that the blocking of the
IGF-1R affected MMP9 gene levels in both MCF7 and MDA-MB-231 cells
overexpressing RIN1.
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Chapter 5
5.1. General Discussion
Endocytosis is a process where cells ingest macromolecules and particles via
membrane bound substances. These events allow cells to digest and also recycle
molecules to the exterior space. This process is called exocytosis and it functions
opposite to endocytosis. These processes regulate several cellular mechanism from
protein secretion, RTK endocytosis, recycling and degradation.

Disruption of

endocytosis within RTK trafficking has been linked to modifications in cellular processes
such as adhesion, migration, proliferation, polarity, asymmetrical division and overall cell
survival and

represent the importance of Rab GTPases in cancer initiation and

progression131.
Rab GTPases are considered to be master regulators of a multitude of trafficking
pathways. Factors such as HGF, EGF, TGFβ and IGF are known to activate the
endosomal and exocytic pathways, thereby altering cell communication with the
environment. The mechanisms can be comparable at key junctions where actin filaments
and integrins are mobilized thereby promoting a migratory response in tumor cells.
These RTKs can be internalized through two principal pathways: clathrin-coated pits or
caveolae. In IGF-1 signaling, recent evidence highlighted an increase in cell proliferation
and inhibition of apoptosis upon IGF-1R stimulation and ensuing internalization via colocalization with clathrin and caveolin-1123. IGF-1R is also localized in the nucleus in
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prostate, renal and breast tumor cells after translocation from the cell surface via clathrin
mediated endocytosis.2
Recently, more attention has been directed to the mechanisms involving cancer
progression and Rab GTPases function131. Cell migration and invasion constitute key
hallmarks of cancer and specifically cancer metastasis69. The transitions to a malignant
and aggressive phenotype by normal cells are site specific 54. It also involves a variety of
Rab proteins that have been implicated in the transition to metastasis where cells become
invasive and penetrate the basal cell membrane and the ECM32,37. These cells secrete an
array of proteases such as MMPs; induce the compromised basement membrane to
further release more proteases such as collagenase and growth factors, thereby allowing
cancer cells to breach the basal membrane and migrate to distal sites.
As the role of growth factor-driven endocytosis in cancer cells is slowly being
characterized, part of the struggle that currently exists involves the correct identification
of the crucial endocytic molecules in growth factor signaling that may be potential
therapeutic targets in cancer treatment. These may include but are not limited to Rab5,
and its effectors49,172. This report outlines an inherent relationship between Rab GTPases
and IGF-1 in cancer cell migration and invasion. Whilst most Rabs are currently not
considered to be oncogenic, this study otherwise provides evidence that some Rabs may
be indeed so.
Here, it is reported for the first time that Rab5 and well as, RIN1, a specific Rab5
GEF, are central players in migration and invasion of MCF7 cells especially in the
intracellular trafficking and signaling of the activated IGFR. The typically non-invasive
MCF7 breast cancer cells were transfected with Rab5WT, Rab5 mutants (the GDP bound
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form Rab5:S34N or GTP bound form Rab5:Q79L) or RIN1WT and the invasive and
migratory potential were investigated. Interestingly, Rab5WT, Rab5:Q79L and RIN1
mediated significant migration and invasion of the tumor cells, with RIN1 and
Rab5:Q79L also showing an induction (though not as significant) in the absence of IGF1. The inactive form of Rab5, Rab5:S34N inhibited proliferation, migration and invasion
of the cancer cells confirming Rab5 must be active and is necessary in IGFR endocytosis
in IGF-1-dependent cancer cells. Further characterization of RIN1 importance in RTK
trafficking was determined when transient silencing of RIN1 expression negated invasion
of tumor cells. Other GEFs of Rab5 were also shown to influence the migratory and
invasive potential of breast cancer cells with RIN3 demonstrating a more profound effect
compared to RIN2.
Given that non-invasive tumor cells were directed to an aggressive status, it was
logical to verify if in an invasive breast cancer cell line, MDA-MB-231, Rab5 and its
GEFs are required in IGF-1 signaling. Using a stably transfected MDA-MB-231 cell line
expressing Rab5:S34N, it was observed that the invasive and migratory properties
increased irrespective of growth factor stimulations while the invasive potential of breast
cancer cell lines expressing the wild type and active (GTP-bound) form of Rab5 were
noticeably greater. Of interest, the expression of RIN1 increased invasion and migration
of MDA-MB-231 cells even in the absence of growth factors. The results obtained
warranted additional inquiry into the mechanism of RIN1 in enabling IGFR intracellular
trafficking and signaling, i.e. through interaction with the receptor itself or only as a
switch in Rab5 activation. The RIN1 mutant, RIN1:R94, possessed an aberration in the
SH2 binding domain. This study clearly illustrated that RIN1 interacts with the cystolic
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tail of the IGFR as cancer cells expressing RIN1:R94A partially mitigated invasion and
migration.
Thus far, IGF-1-induced migration and invasion of breast cancer cells necessitate
active Rab5 sequestration via RIN1 activity. Consequently it was crucial to validate
previous findings and ascertain if IGFR trafficking was caveolin dependent. IGF-1
treatment of MCF7 cells induced morphological changes consistent with EMT
particularly in Rab5 and RIN overexpressing cells, i.e. more elongated and fibroblastlike. When kinase inhibitor for IGFR, AG1024 and caveolin inhibitor, Filipin, were
administered to both MCF7 and MDA-MB-231 expressing, GFP, Rab5 or RIN1
constructs, the inhibitors impaired the migratory and invasive response of the breast
cancer cell lines, suggesting that IGFR phosphorylation and internalization of the
activated receptor was mediated by caveolin and caveosome formation upon IGF-1
stimulation. How does Rab5 and RIN1 fit into this schematic? Analysis of mRNA
expression indicated that blocking of the IGFR or disruption of caveolin signaling in
breast cancer cells expressing GFP or RIN1, suppressed Rab5 gene expression as well
MMP9 secretion. The latter substantiates cell invasion data where the inhibitors averted
the phosphophorylation of the IGFR and its internalization despite RIN1 and Rab5
overexpression. Overexpression of Rab5 induced a significant increase in MMP9
expression and down-regulation in the presence of the inhibitors. In summation, this
study illustrates a novel model in IGF-1 signaling in breast cancer progression. IGF-1
signaling is contingent on the IGF-1R phosphorylation and caveolae internalization via
Rab5 and RIN1 function. Furthermore, it is reported that there may be a link between
caveolin-dependent endocytosis and RIN1 activation in IGF-1 signaling. RIN1
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overexpression has been shown to increase endogenous caveolin-1 in early endosomes,
and upon internalization, translocation and tethering of active caveosomes to the early
endosomes is

Rab5 dependent154.

Therefore, the relationship between IGF-1R

trafficking and MMP9 production is dependent on the activity of early endocytic
trafficking machinery; thus RIN1 and Rab5 GTPases function within invading breast
cancer cells.

5.2 Future Plans
Endocytosis is an indispensable molecular mechanism in growth factor induced
signaling, and it is worth considering that early factors such as small GTPases and its
GEFs exert a great influence on intracellular trafficking. Most importantly it is a
coordinator in the crosstalk amongst signaling pathways in the propagating and
promoting cancer cell survival. Further description of these small GTPases (e.g. Rab)
function in cancer cell proliferation, migration and invasion, would be beneficial as these
Rabs can be prospective biomarker in determining cancer stage and outcome prognosis.
This idea opens the doors for the development of new therapeutic methods to target these
necessary factors such as siRNA or peptide manipulations that can selectively affect Rab
effectors.
While this study also demonstrates that Rab5 is a central player in the migration and
invasion of cancer cells especially in response to IGF-1 stimulation, other questions
abound including the role or activity of downstream effectors (PI3K and MAPK) in
facilitating cell migration and invasion and as well as the mobilization of cytoskeletal
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proteins such as focal adhesion kinase (FAK) and integrin receptor in IGF-1 mediate
cancer progression. Even though it has been suggested that Rab5 modulates focal
adhesion kinase activity in normal and cancer cells 127, yet little information is available
as to how growth factors (i.e. IGF-1) regulate the molecular mechanisms of intracellular
processes leading to survival in normal and cancer cells.
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